March 2025 Content Release Copied
Clinical Profile Documentation
Problem Groups
Additions
The Problems > Add Details area is updated with applicable documentation points for the following diagnoses.
ALK status has been updated for Non-small cell lung and Uterine cancers with the following documentation points:
- Positive
- Negative
- Unknown
ERBB2 (HER2) mutation status has been updated for Non-small cell lung cancer with the following documentation points:
- Positive
- Negative
- Variant of uncertain significance
- Unknown
FOLFR1 expression has been updated for Fallopian tube and Ovarian and Peritoneal cancers
with the following documentation points:
- >/= 75%
- >/=50% and <75%
- >/=25% and <50%
- >0 and <25%
- 0%
- Unknown
HER2 by IHC has been updated for Breast cancer with the following documentation points:
- P3+ (HER2+)
- 2+ (Equivocal)
- 1+ (HER2-, low)
- 0+, faint, partial membrane staining in < or = 10% (HER2-, ultralow)
- 0, no membrane staining (HER2-)
- Unknown
KRAS status has been updated for Colon, Pancreatic, Non-small cell lung, and Rectal cancers with the following documentation points:
- KRAS G12C mutation
- Wild type
- Unknown
- Other non-actionable finding
KRAS status is now available for Bile Duct and Gallbladder cancers with the following documentation points:
- KRAS G12C mutation
- Wild type
- Unknown
- Other non-actionable finding
MET exon 14 skipping status has been updated for Non-small cell lung cancer with the following documentation points:
- Exon 14 skipping mutation
- Negative
- Unknown
PALB2 status has been updated for Breast cancer with the following documentation points:
- Mutation
- Wild type
- Unknown
POLD1 status with ultra-hypermutated phenotype has been updated for Colon and Rectal cancers with the following documentation points:
- Mutation
- Wild type
- Unknown
POLE status with ultra-hypermutated phenotype has been updated for Colon and Rectal cancers with the following documentation points:
- Mutation
- Wild type
- Unknown
Tumor mutational burden (TMB)-tissue status has been updated for Solid tumor cancers with the following documentation points:
- High (>/= 10 mut/Mb)
- Low (<10 mut/Mb)
- Unknown
AJCC Version 9 Staging
Updates
This release contains updated TNM values, Staging Groups, and Template functionality to align with AJCC version 9 conditions for:
- Lung cancer, Non Small cell (NSCLC)
- Lung cancer, Small cell (SCLC)
Users will see updated values and descriptions for Primary Tumor Type (T), Regional Lymph Nodes (N), and Distance Metastasis (M), documentation points:
The following Distance Metastasis (M) value is no longer available:
- MX
The following Distance Metastasis (M) values are now available:
- M1c1
- M1c2
The following Primary Tumor Type (T) documentation points updated descriptions:
| T Value | Description |
| T1a | Tumor <= 1 cm in greatest dimension or Tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus, this is an uncommon superficial, spreading tumor |
| T2a | Tumor > 3 cm but <= 4 cm in greatest dimension OR Tumor <= 4 cm in greatest dimension with one or more of the following features: (Invades visceral pleura, Invades an adjacent lobe, Involves main bronchus (up to but not including the carina) or associated with atelectasis or obstructive pneumonitis, extending to the hilar regions, involving either part of or the entire lung) |
| T2b | Tumor > 4 cm but <= 5 cm in greatest dimension with or without any of the following features: (Invades visceral pleura, Invades an adjacent lobe, Involves main bronchus (up to but not including the carina) or associated with atelectasis or obstructive pneumonitis, extending to the hilar regions, involving either part of or the entire lung) |
|
T3 |
Tumor > 5 cm but <= 7 cm in greatest dimension OR Tumor <= 7 cm with one or more of the following features: (Invades parietal pleura or chest wall, invades pericardium, phrenic nerve or azygos vein – although these structures lie within the mediastinum, the degree of mediastinal penetration by the tumor needed to invade these structures is not counted as T4, Invades thoracic nerve roots (i.e., T1, T2) or stellate ganglion, Separate tumor nodule(s) in the same lobe as the primary) |
|
T4 |
Tumor > 7 cm in greatest dimension OR Tumor of any size with one or more of the following features (Invades mediastinum (except structures listed in T3), thymus, trachea, carina, recurrent laryngeal nerve, vagus nerve, esophagus or diaphragm intrapericardial pulmonary arteries/veins), supra-aortic arteries or brachiocephalie veins, Invades subclavian vessels, vertebral body, lamina, spinal canal, cervical nerve roots or brachial plexus (i.e., trunks, divisions, cords, or terminal nerves), Separate tumor nodule(s) in a different ipsilateral lobe than that of the primary) |
The following Regional Lymph Nodes (N) documentation points have updated descriptions:
| N Value | Description |
| N0 | No tumor involvement of regional lymph node(s) |
| N1 | Tumor involvement of ipsilateral peribronchial and/or ipsilateral hilar and/or ipsilateral intrapulmonary lymph node station(s), including involvement by direct extension |
| N2a | Tumor involvement of a single ipsilateral mediastinal nodal station or of the subcarinal lymph node station |
| N2b | Tumor involvement of multiple ipsilateral mediastinal nodal stations with or without involvement of the subcarinal lymph node station |
| N3 | Tumor involvement of contralateral mediastina, contralateral hilar, ipsilateral/contralateral scalene, or ipsilateral/contralateral supraclavicular lymph node station(s) |
The following Distance Metastasis (M) documentation points have updated descriptions:
| M Value | Description |
| M1a | Metastasis in pleural or pericardial nodules, and/or malignant pleural or pericardial effusions, and/or separate tumor nodule(s) in a contralateral lobe Note: Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is non-bloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor. |
| M1b | Single extrathoracic metastasis in a single organ system (including involvement of a single non-regional node |
| M1c1 | Multiple extrathoracic metastases in a single organ system.
For example, the skeleton is considered one organ. Several metastases in a single bone or several metastases in several bones are classified as M1c1 |
| M1c2 | Multiple extrathoracic metastases in multiple organ systems |
Problem Mapping
Additions
New items are available for documentation in Clinical Profile > Problems and appear in the Charge Capture Report (CCR). Additional ICD-10 codes may be displayed to present the surrounding nodes.
Please see APPENDIX A for a complete summary of changes.
Updates
Location documentation points for Breast Cancer, Male have been updated to autopopulate the corresponding ICD-10-CM codes:
| Category | Code | Description |
| Nipple and areola unspecified | C50.029 | Malignant neoplasm of nipple and areola, unspecified male breast |
| Central portion unspecified | C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| Left breast lower-inner quadrant | C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| Lower-inner quadrant unspecified | C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| Upper-outer quadrant unspecified | C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| Lower-outer quadrant unspecified | C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| Left breast axillary tail | C50.622 | Malignant neoplasm of axillary tail of left male breast |
| Axillary tail unspecified | C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| Right breast axillary tail | C50.621 | Malignant neoplasm of axillary tail of right male breast |
Billing & HCPCS Codes
Additions
The April 2025 updates include new HCPCS Level II codes to separately identify products approved under the 505(b)(2) New Drug Application (NDA) or the Biologics License Applications (BLA) pathways after October 2003 and not rated as therapeutically equivalent to a reference listed product in an existing code. A complete application summary and coding link can be found here.
Please visit CMS’s website for a complete list of April 2025 HCPCS Quarterly update.
The following products have not been released per First Databank (FDB):
- Q5149 – Aflibercept-abzv (enzeevu)
- Q5150 – Aflibercept-mrbb (ahzantive)
Updates
The following codes HCPCS codes will be effective April 1, 2025.
| Medication | Code(s) |
| Afamitresgene autoleucel IV | Q2057 per tx dose |
| Aflibercept-ayyh Intravitreal 2 mg/0.05 mL (Pavblu) | Q5147 per 1 mg |
| Aminocaproic Acid IV | J0281 per 1 g |
| Atezolizumab-hyaluronidase-tqjs Subcutaneous 1,875 mg-30,000 unit/15 mL | J9024 per 5 mg |
| Axatilimab-csfr IV | J9038 per 0.1 mg |
| Belantamab Mafodotin-blmf IV | J9037 per 0.5 mg |
| Bortezomib IV (Boruzu) | J9054 per 0.1 mg |
| Bortezomib Subcutaneous (Boruzu) | J9054 per 0.1 mg |
| Eculizumab IV | J1299 per 2 mg |
| Eculizumab-aagh IV (Epysqli) | Q5151 per 2 mg |
| Eculizumab-aeeb IV (Bkemv) | Q5152 per 2 mg |
| Famotidine (PF) IV | J1308 per 0.25 mg |
| Famotidine IM | J1308 per 0.25 mg |
| Famotidine IV | J1308 per 0.25 mg |
| Filgrastim-txid Continuous Subcutaneous Infusion (Nypozi) | Q5148 per 1 mcg |
| Filgrastim-txid IV (Nypozi) | Q5148 per 1 mcg |
| Filgrastim-txid Subcutaneous (Nypozi) | Q5148 per 1 mcg |
| Folic Acid IM | J1808 per 0.1 mg |
| Folic Acid IV | J1808 per 0.1 mg |
| Folic Acid Subcutaneous | J1808 per 0.1 mg |
| Furosemide IM | J1938 per 1 mg |
| Furosemide IV | J1938 per 1 mg |
| Ocrelizumab-hyaluronidase-ocsq Subcutaneous 920 mg-23,000 unit/23 mL | J2351 per 1 mg |
| Paliperidone IM (monthly) (Erzofri) | J2428 per 1 mg |
| Rifampin IV | J2804 per 1 mg |
| Sodium Chloride IV 3 % | J7131 per 1 mL |
| Sodium Chloride IV 5 % | J7131 per 1 mL |
| Sulfamethoxazole-Trimethoprim IV 80 mg-16 mg/mL | J2865 per: 1 mg & 5 mg |
| Testosterone Cypionate IM (Azmiro) | J1072 per 1 mg |
| Ustekinumab-aauz IV (Otulfi) | Q9999 per 1 mg |
| Ustekinumab-aauz Subcutaneous (Otulfi) | Q9999 per 1 mg |
Removals
The following HCPCS codes will be discontinued on March 31, 2025.
| Medication | Code(s) |
| Belantamab Mafodotin-blmf IV | J9037 per 0.5 mg |
| Eculizumab IV | J1300 per 10 mg |
| Eculizumab-aeeb IV (Bkemv) | Q5139 per 10 mg |
| Furosemide IM | J1940 per 20 mg |
| Furosemide IV | J1940 per 20 mg |
| Melphalan Flufenamide IV | J9247 per 1 mg |
Lab Analytes & Panels
Additions
- ANA screen by IFA
- Antiparietal cell ab interpretation
- Antiphospholipid antibody, IgM, U/mL
- Artifact
- Blood culture molecular detection
- Blood culture molecular detection panel
- BRCANext
- Cannabinoids 11-nor-9-carboxy-THC, S/P, quant, ng/mL
- Catecholamine interpretation
- Ceftazimide/avibactam
- Cefuroxime/axetil
- Coxsackie ,GRP.A (24)
- Coxsackie virus Ab, GRP A panel
- Deoxypyridinoline, urine
- Dopamine, blood, pmol/L
- dsDNA AB, IgG, IU/mL
- Dysmorphic RBC
- Epinephrine, blood, pmol/L
- Flow panel: leukemia/lymphoma
- Fosfomycin
- Foundation medicine report
- FoundationOne Ventana FOLR1 (FOLR1-2.1) RxDx
- Genetic analysis overall interpretation
- High risk HPV, cervical
- HIV-1 RNA
- HIV-2 RNA
- JAK2 V617F reflex
- Lyme IgG/IgM Abs
- Myriad report
- NeoTYPE Lung Tumor Profile with reflex to InVisionFirst-Lung Liquid Biopsy if tissue NGS is insufficient panel
- NeXT Personal Dx panel
- Norepinephrine, blood, pmol/L
- Nucleated cells
- Parietal cell ab Interpratation
- Quantiferon, mitogen minus NIL
- Single-site include gene and mutation name
- TEG delta
- TEG description
- TEG G (clot strength)
- TEG lysis 30
- TEG net clot strength (net G)
- TEG split time (SP)
- Thyroglobulin tumor marker interpretation
- Trichomonas, NAAT, urine
- West nile virus IgG, CSF
Medications
Additions
- ABBV-291 invest IV
- Amivantamab-rHuPH20 invest (JNJ-61186372-rHuPH20 invest Subcutaneous)
- ASTX030 invest Oral
- BMS-986489 (BMS-986012 (Atigotatug)-Nivolumab FDC) invest IV
- CHS-114 invest IV
- Ensartinib invest (X-396 invest Oral)
- JNJ-61186372-rHuPH20 invest Subcutaneous
- N-803 invest Intravesical
- NVL-655 invest Oral
- Odronextamab invest (REGN1979 invest IV)
- REGN1979 invest IV
- REGN7075 invest IV
- Rilvegostomig (AZD2936) 750 mg or Pembrolizumab 200 mg invest IV
- X-396 invest Oral
- XB010 invest IV
Updates
| Medications | Updates |
| ABBV-399 invest IV | New Alias available:
|
| datopotamab deruxtecan-dlnk IV | New Maximum Single Dose available:
New Instructions available: Max dose 540 mg (based on max weight 90 kg). Dilute in infusion bag made of polyvinylchloride or polyolefin (polypropylene or copolymer of ethylene and propylene). Gently invert to mix. Do not shake. Administer with an infusion line and tubing set made of polyvinyl chloride, polybutadiene or low-density polyethylene and 0.2-micron in-line polytetrafluoroethylene, polyethersulfone or nylon 66 filter. Do not give IV push or bolus. Protect from light. Do not mix with other drugs. First infusion: Administer over 90 minutes. Observe patient during the infusion and for at least 1 hour after infusion. Second Infusion: If first infusion was tolerated, administer over 30 minutes. Observe patient during the infusion and for at least 1 hour after infusion. Subsequent Infusions: Administer infusion over 30 minutes if prior infusions were tolerated. Observe patients during the infusion and for at least 30 min after infusion. Instruct patient to hold ice chips or ice water in the mouth |
| Luspatercept-aamt Subcutaneous | New Maximum Single Dose available:
Maximum Single Dose:
|
| nilotinib Oral (Danziten) | New Maximum Single Dose available:
|
| PC14586 invest Oral | New Alias available:
|
| revumenib Oral | New Maximum Single Dose available:
New Instructions available:
|
| trastuzumab-strf IV | New Rounding Rule available:
New Maximum Single Dose available:
New Instructions available:
|
| XmAb20717 invest IV | New Quick SIG Pick available:
|
Regimen Library
Additions
| Regimen Name | Diagnosis |
| Acalabrutinib + Bendamustine D1,2 + Rituximab IV Q28D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
| Acalabrutinib + Obinutuzumab + Venetoclax Q28D (CLL) | Leukemia, Chronic Lymphocytic (CLL) |
| Acalabrutinib + Venetoclax Q28D (CLL) | Leukemia, Chronic Lymphocytic (CLL) |
| Axatilimab-csfr Q14D | Graft Versus Host Disease (GVHD) |
| Cabozantinib (Cabometyx) Q30D (RCC, HCC, Differentiated Thyroid, Uterine, Neuroendocrine Tumor) | Hepatocellular Carcinoma (HCC); Renal Cell Carcinoma (RCC); Thyroid Cancer (Parent); Uterine Cancer (Parent); Neuroendocrine Tumor, Carcinoid (Parent) |
| Dostarlimab-gxly + Paclitaxel D1,8,15 + Carboplatin D1,8,15 Q21D | Uterine Cancer (Parent) |
| Epcoritamab-bysp (Epkinly) SQ D1,8,15,22 fb D1,15 fb D1 + Gemcitabine + Oxaliplatin (GemOx) C1-4 D1,15 Q28D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
| Guselkumab IV Q28D Induction (Ulcerative Colitis) | Ulcerative Colitis |
| Guselkumab SQ (100 mg) Q56D Maintenance (Ulcerative Colitis) | Ulcerative Colitis |
| Guselkumab SQ (200 mg) Q28D Maintenance (Ulcerative Colitis) | Ulcerative Colitis |
| Nivolumab SQ + Cetuximab Q14D | Head and Neck Cancer (Parent) |
| Nivolumab SQ + Gemcitabine D1,8 + Cisplatin Q21D (Bladder) | Bladder Cancer; Renal Pelvis and Ureter Cancer; Urethral Cancer |
| Nivolumab SQ + Pemetrexed + Carboplatin Q21D (Neoadjuvant NSCLC) | Lung Cancer, Non-small Cell (NSCLC) |
| Nivolumab SQ + Pemetrexed + Cisplatin Q21D (Neoadjuvant NSCLC) | Lung Cancer, Non-small Cell (NSCLC) |
| Nivolumab SQ D1,15 fb D1 Q28D (Adjuvant Esophageal) | Esophageal Cancer (Parent) |
| Nivolumab SQ Maintenance Q14D | Colon Cancer; Hepatocellular Carcinoma (HCC); Melanoma, Skin; Neuroendocrine Tumor, Carcinoid (Parent); Pancreatic Cancer, Carcinoid/Neuroendocrine; Rectal Cancer; Renal Cell Carcinoma (RCC) |
| Pembrolizumab (Flat Dose) + Paclitaxel D1,8,15,22,29,36 + Carboplatin D1,22 Q42D fb Pembrolizumab (Flat Dose) + Doxorubicin + Cyclophosphamide (AC) D1,22 Q42D | Breast Cancer |
| Pembrolizumab (Flat Dose) + Paclitaxel D1,8,15,22,29,36 + Carboplatin | Breast Cancer |
| D1,8,15,22,29,36 Q42D fb Pembrolizumab (Flat Dose) + Doxorubicin + Cyclophosphamide (AC) D1,22 Q42D | |
| Pembrolizumab (Flat Dose) + Doxorubicin + Cyclophosphamide (AC) D1,22 Q42D fb Pembrolizumab (Flat Dose) + >Paclitaxel D1,8,15,22,29,36 + Carboplatin D1,8,15,22,29,36 Q42D | Breast Cancer |
| Pembrolizumab (Flat Dose) + Doxorubicin + Cyclophosphamide (AC) D1,22 Q42D fb Pembrolizumab (Flat Dose) + Paclitaxel D1,8,15,22,29,36 + Carboplatin D1,8,15,22,29,36 Q42D | Breast Cancer |
| Tafasitamab-cxix D1,8,15,22 fb D1,15 + Lenalidomide D1-21 + Rituximab IV D1,8,15,22 fb D1 Q28D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
Updates
Regimens for the following diagnoses have been updated based on the Collaborative Care Committee voting. Changes include but are not limited to reference update, drug infusion instruction updates, renaming of regimens, premedication template updates and number of cycles.
- Anal Cancer (Parent)
- All Problems
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colon Cancer
- Cutaneous Carcinoma, Basal Cell
- Cutaneous Carcinoma, Squamous Cell
- Hepatocellular Carcinoma (HCC)
- Lung Cancer, Non-small Cell (NSCLC)
- Lymphoma, Non-Hodgkin (NHL) (Parent)
- Multiple Myeloma (MM)
- Myasthenia Gravis
- Neuroendocrine Tumor, Carcinoid (Parent)
- Prostate Cancer
- Rectal Cancer
- Renal Cell Carcinoma (RCC)
- Renal Pelvis and Ureter Cancer
- Thyroid Cancer (Parent)
- Urethral Cancer
- Uterine Cancer (Parent)
Renames
| Previous Name | New Name |
| Amivantamab-vmjw (weight greater than or equal to 80 kg) + Pemetrexed + Carboplatin Q21D | Amivantamab-vmjw + Pemetrexed + Carboplatin Q21D fb Amivantamab-vmjw + Pemetrexed Q21D Maintenance (Weight greater than or equal to 80 kg) |
| Amivantamab-vmjw (weight less than 80 kg) + Pemetrexed + Carboplatin Q21D | Amivantamab-vmjw + Pemetrexed + Carboplatin Q21D fb Amivantamab-vmjw + Pemetrexed Q21D Maintenance (Weight less than 80 kg) |
| Cabozantinib (Cabometyx) Q30D (RCC, HCC, Differentiated Thyroid, Uterine) | Cabozantinib (Cabometyx) Q30D (RCC, HCC, Differentiated Thyroid, Uterine, Neuroendocrine Tumor) Dose Optimization |
| Gemcitabine + Oxaliplatin (GemOx) C1 D2 fb C3-8 D1 + Obinutuzumab D1 fb Glofitamab- gxbm (Columvi) D8,15 fb D1 Q21D | Gemcitabine + Oxaliplatin (GemOx) D2 fb D1 + Obinutuzumab fb Glofitamab-gxbm (Columvi) D8,15 fb D1 Q21D |
| Isatuximab-irfc IV + Lenalidomide + Bortezomib + Dexamethasone (RVD) Q42D (Part 1 of 2: Induction) | Isatuximab-irfc IV + Lenalidomide + Bortezomib + Dexamethasone (RVD) Q42D (Induction , transplant candidates) |
Removals
Regimen Consolidation
The following regimens have been inactivated as part of the Reference Regimen / Biosimilar Merge initiative.
- Paclitaxel + Gemcitabine D1,8 Q21D (Bladder)
- Amivantamab-vmjw (weight less than 80 kg) + Pemetrexed Q21D Maintenance
- Amivantamab-vmjw (weight greater than or equal to 80 kg) + Pemetrexed Q21D Maintenance
The following regimens are no longer available:
| Regimen Name | Diagnosis |
| Paclitaxel + Gemcitabine D1,8 Q21D (Bladder) | Bladder Cancer, Renal Pelvis and Ureter Cancer, Urethral Cancer |
| Amivantamab-vmjw (weight less than 80 kg) + Pemetrexed Q21D Maintenance | Lung Cancer, Non-small Cell (NSCLC) |
| Amivantamab-vmjw (weight greater than or equal to 80 kg) + Pemetrexed Q21D Maintenance | Lung Cancer, Non-small Cell (NSCLC) |
Appendix A
NDC – HCPCS Crosswalk
Additions
For medications listed below that include a brand name, please refer to the NDC – HCPCS crosswalk table within the release notes for specific dispensable/NDC association.
| Medication | Code(s) |
| bimekizumab-bkzx Subcutaneous | J3590 per 320 mg |
| bimekizumab-bkzx Subcutaneous Auto-Injector | J3590 per 320 mg |
| Buprenorphine Subcutaneous ER Solution (Sublocade) | Q9992 Per 1 dose |
| Concizumab-mtci Subcutaneous Pen Injector | J3590 per 300 mg |
| Cyclophosphamide IV (Frindovyx) | J9072 per 5 mg |
| Donanemab-azbt IV (Kisunla) | J0175 per 2 mg |
| Filgrastim-txid Continuous Subcutaneous Infusion | J3590 per 480 mg |
| Filgrastim-txid IV | J3590 per 480 mg |
| Filgrastim-txid Subcutaneous | J3590 per 480 mg |
| Kit for Tc 99m-sod thiosulfate IV | A9541 per 37 MBq |
| Kit for Tc 99m-sod thiosulfate Subcutaneous | A9541 per 37 MBq |
| Marstacimab-hncq Subcutaneous Pen Injector | J3590 per 150 mg |
| Metreleptin Subcutaneous | J3590 per 5 mg |
| Paclitaxel-Protein Bound IV | J9264 per 1 mg |
| Peginterferon Alfa-2a Subcutaneous | J3590 per 180 mcg |
| Pegvisomant Subcutaneous | J3590 per 15 mg |
| Ropeginterferon alfa-2b-njft Subcutaneous | J9999 per 500 mcg |
| Sodium Chloride IV 3 % | J3490 per 500 mL |
| Sodium Chloride IV 5 % | J3490 per 500 mL |
| Tesamorelin Subcutaneous | J3590 per 2 mg |
| Testosterone Cypionate IM | J3490 per 200 mg |
| Treosulfan IV | J9999 per 10 g |
| Ustekinumab-aauz IV | J3590 per 130 mg |
| Ustekinumab-aauz Subcutaneous | J3590 per 45 mg |
| Ustekinumab-aekn Subcutaneous (Selarsdi) | Q9998 per 1 mg |
| Ustekinumab-kfce IV | J3590 per 130 mg |
| Ustekinumab-kfce Subcutaneous | J3590 per 45 mg |
| Ustekinumab-stba IV | J3590 per 130 mg |
| Ustekinumab-stba Subcutaneous | J3590 per 45 mg |
| Ustekinumab-ttwe IV (Pyzchiva) | Q9997 per 1 mg |
| Ustekinumab-ttwe Subcutaneous (Pyzchiva) | Q9996 per 1 mg |
Updates
The following HCPCS codes and NDCs will be effective April 1, 2025. The CMS ASP pricing can be found here.
| Medication | Codes | NDC |
| Buprenorphine Subcutaneous ER Solution (Sublocade) | Q9992 Per 1 dose | 12496010002 12496010001 12496010005 12496030001 12496030002 12496030005 |
| Cyclophosphamide IV (Frindovyx) | J9072 per 5 mg | 83831012104 83831012002 83831011901 |
| Donanemab-azbt IV (Kisunla) | J0175 per 2 mg | 00002940101 |
| Ustekinumab-aekn Subcutaneous (Selarsdi) | Q9998 per 1 mg | 51759050532 51759060732 |
| Ustekinumab-ttwe IV (Pyzchiva) | Q9997 per 1 mg | 61314065494 |
| Ustekinumab-ttwe Subcutaneous (Pyzchiva) | Q9996 per 1 mg | 61314065101 61314065201 |
| Aflibercept-ayyh Intravitreal 2 mg/0.05 mL (Pavblu) | Q5147 per 1 mg | 55513006501 55513005601 |
| Bortezomib IV (Boruzu) | J9054 per 0.1 mg | 70121248401 |
| Bortezomib Subcutaneous (Boruzu) | J9054 per 0.1 mg | 70121248401 |
| Eculizumab-aagh IV (Epysqli) | Q5151 per 2 mg | 51759020813 |
| Eculizumab-aeeb IV (Bkemv) | Q5152 per 2 mg | 55513018001 |
| Filgrastim-txid Continuous Subcutaneous Infusion (Nypozi) | Q5148 per 1 mcg | 72374010101 72374010110 72374010201 72374010210 |
| Filgrastim-txid IV (Nypozi) | Q5148 per 1 mcg | 72374010101 72374010110 72374010201 72374010210 |
| Filgrastim-txid Subcutaneous (Nypozi) | Q5148 per 1 mcg | 72374010101 72374010110 72374010201 72374010210 |
| Paliperidone IM (monthly) (Erzofri) | J2428 per 1 mg | 72526010711 72526010811 72526010911 72526011011 72526010511 72526010611 |
| Testosterone Cypionate IM (Azmiro) | J1072 per 1 mg | 24338005501 |
| Ustekinumab-aauz IV (Otulfi) | Q9999 per 1 mg | 65219082805 |
| Ustekinumab-aauz Subcutaneous (Otulfi) | Q9999 per 1 mg | 65219082401 65219082626 |
Professional Services
Additions
The following Professional Services codes and short descriptions will be effective April 1, 2025.
| Description | Codes |
| NFCT DS AFB&INVAS FUNGI DNA 673 ORGS NGS PLASMA | 0531U |
| RARE DS RAPID WHL GEN&MITOCHDRL DNA SEQ SNV SLV | 0532U |
| RX METAB ADVRS RX RXN&RSPSE GNOTYP 16 GENES | 0533U |
| ONC PRST8 MIRNA SNP ALYS RT-PCR 32VRNT BUCC SWAB | 0534U |
| PFAS LC-MS/MS PLASMA/SERUM QUANTITATIVE | 0535U |
| RBC AG FETAL RHD PCR ALYS EXON 4 RHD GENE&GAPDH | 0536U |
| ONC CLRCT CA ALYS CFDNA EPIG PTRN NGS >2500 DMR | 0537U |
| ONC SOLID TUM NGTS ALYS FFPE DNA ALYS 600 GENES | 0538U |
| ONC SOLID TUMOR CFCTDNA 152 GEN NGS INTERROG SNV | 0539U |
| TRNSPLJ MEDICINE QUAN DD-CFDNA NGS ALYS PLASMA | 0540U |
| CV DS HDL RCT CEC LC-MS/MS 5HDL-BD APO SERUM ALG | 0541U |
| NEFRO RENAL TRNSPL URINE NMR 84 UR METABOLITES | 0542U |
| ONC SOL TUM NGS DNA FFPE TISS 517GEN INTEROG SNV | 0543U |
| NEFRO TRANSPLANT MNTR 48 VRNTS DPCR CFDNA PLASMA | 0544U |
| ACHR ANTIBODY ID IMMUNOFLUORESCENCE LIVE CELLS | 0545U |
| LOW DNS LRP4 ANTB ID IMMUNOFLUORESCENCE LIVE CLL | 0546U |
| NEURFLMNT LIGHT CHAIN CLEIA PLASMA QUANTITATIVE | 0547U |
| GLIAL FIBRILLARY ACIDIC PROTEIN CLEIA PLASMA | 0548U |
| ONC URTHL DNA QUAN MTHYLTD RT PCR TRNA-CYS SIM2 | 0549U |
| ONCOLOGY PROSTATE ELISA TOTAL&FREE PSA SERUM | 0550U |
| TAU PHOSPHORYL PTAU217 ULTRSENS DGTL PRTN DETCJ | 0551U |
Problem (SNOMED) Summary
Removals
The standard body has retired the following concepts. Where applicable, a replacement concept has been provided:
| Description | Replacement |
| 10*12 cells/L | None |
| 10*12/L | None |
| 10*6 cells/L | None |
| 10*6 spermatozoa /ejaculate | None |
| 10*6/L | None |
| 10*9 cells/L | None |
| 10*9 Platelets/L | None |
| 10*9/L | None |
| 11-deoxysteroid | None |
| 3-(p-Chlorophenyl)-1, 1-dimethyl urea | None |
| Abdominal aortography with bilateral iliofemoral arteries with serialography | Fluoroscopic angiography of abdominal aorta and bilateral iliac and femoral arteries with contrast |
| Abdominal aortography, positive contrast | None |
| Abdominal fistulography with contrast | None |
| Abdominal part of vas deferens | None |
| Abortifacient agent | None |
| Abuse of drugs to lose weight | None |
| Abuse of partner | None |
| Acaricide agent | Acaricide |
| Acrocephalopolysyndactyly type IV | Acrocephalopolysyndactyly type II |
| Activity of daily living needs met | None |
| Acute mastoiditis with complication | Acute mastoiditis |
| Acylaminopenicillin antibacterial agent | None |
| Adhesive agent | Adhesive agent |
| Affective personality trait | None |
| Air meatogram | None |
| Air myelogram | Myelogram |
| Aldosterone receptor antagonist diuretic agent | None |
| All bone marrow of pelvis and femur | None |
| Allergy to calcium channel blocker | None |
| Alpha-carboxypenicillin antibacterial agent | None |
| Ambigrade operative pancreatography | None |
| Aminoglycoside antibacterial agent | None |
| Aminopenicillin antibacterial agent | None |
| Aminoquinoline antimalarial agent | None |
| Amniotic fluid pulmonary embolism with antenatal complication | Amniotic fluid embolism |
| Amniotic fluid pulmonary embolism with postnatal complication | Amniotic fluid embolism |
| Amphenicol antibacterial agent | None |
| Analeptic agent | None |
| Analgesic agent | Analgesic |
| Anesthetic agent | Anesthetic |
| Angiocardiography by serialography, multi-plane | None |
| Angiocardiography by serialography, single plane | None |
| Angiocardiography, positive contrast | None |
| Angioplasty of abdominal aorta | None |
| Angioplasty of abdominal vascular structure | None |
| Angioplasty of aorta | None |
| Angioplasty of aorta with prosthesis | None |
| Angioplasty of arterial graft | None |
| Angioplasty of artery of lower extremity | None |
| Angioplasty of axillary artery | None |
| Angioplasty of brachial artery | None |
| Angioplasty of branches of abdominal aorta | None |
| Angioplasty of carotid artery | None |
| Angioplasty of common femoral artery with prosthesis | None |
| Angioplasty of common femoral artery with vein | None |
| Angioplasty of external carotid artery | None |
| Angioplasty of external iliac artery with prosthesis | None |
| Angioplasty of femoral artery | None |
| Angioplasty of inferior vena cava | None |
| Angioplasty of internal carotid artery | None |
| Angioplasty of narrowed blood vessel lumen | Angioplasty of blood vessel |
| Angioplasty of popliteal artery with prosthesis | None |
| Angioplasty of popliteal artery with vein | None |
| Angioplasty of renal artery | None |
| Angioplasty of subclavian artery | None |
| Angioplasty of superficial femoral artery with prosthesis | None |
| Angioplasty of superficial femoral artery with vein | None |
| Angioplasty of superior vena cava | None |
| Angioplasty of thoracic aorta | None |
| Angioplasty of tibioperoneal artery | None |
| Angioplasty of transverse sinus of brain with insertion of stent | None |
| Angioplasty of vertebral artery | None |
| Angioplasty using paclitaxel coated balloon catheter | None |
| Anion exchange resin agent | Anion exchange resin |
| Antacid agent | Antacid |
| Antegrade pyelogram | Fluoroscopic antegrade pyelography |
| Antegrade urography | Fluoroscopic antegrade pyelography |
| Antenatal deep vein thrombosis with antenatal complication | Antepartum deep vein thrombosis |
| Anthelmintic agent | Anthelmintic |
| Anthracycline antineoplastic agent | None |
| Anthraquinone laxative agent | None |
| Antiacne agent | None |
| Antianemic agent | Hematinic |
| Antiarrhythmic agent | Antiarrhythmic agent |
| Antiasthmatic agent | None |
| Antibacterial agent | Antibacterial |
| Antibiotic | Antibacterial |
| Anticoagulant agent | Anticoagulant |
| Anticonvulsant agent | Anticonvulsant |
| Antidementia agent | None |
| Antidepressant agent | Antidepressant |
| Antidiabetic agent | None |
| Antidiarrheal agent | None |
| Antidote agent | Antidote |
| Antiemetic agent | None |
| Antifungal agent | Antifungal |
| Antiglaucoma agent | None |
| Antiinfective agent | Anti-infective agent |
| Antiinflammatory agent | None |
| Antileprotic agent | Antileprotic drug |
| Antilipemic agent | Antilipemic agent |
| Antimalarial agent | Antimalarial |
| Antimigraine agent | None |
| Antimycobacterial agent | Antimycobacterial |
| Antineoplastic agent | Antineoplastic agent |
| Antiobesity agent | None |
| Antiparasitic-containing product | None |
| Antiparkinson agent | Antiparkinsonian agent |
| Antiprotozoal agent | Antiprotozoal |
| Antipseudomonal penicillin antibacterial agent | None |
| Antipsychotic agent | Anti-psychotic agent |
| Antiretroviral agent | Antiretroviral |
| Antirheumatic agent | None |
| Antiseborrheic agent | None |
| Antiseptic agent | None |
| Antispasmodic agent | Antispasmodic |
| Antithyroid agent | Antithyroid agent |
| Antitubercular agent | Antituberculosis agent |
| Antitussive agent | Antitussive agent |
| Antivaricose agent | Antivaricose agent |
| Antiviral agent | Antiviral |
| Anus transplantation | None |
| Anxiety in pregnancy | None |
| Anxiolytic agent | Anxiolytic agent |
| Arcanobacterial mastitis | None |
| Arginine carboxypeptidase | None |
| Arthralgia of the upper arm | None |
| Arthritis associated with another disorder | None |
| Arthroderma persicolor | None |
| Ascariasis with intestinal complications | Ascariasis |
| Ascorbic acid supplement agent | Vitamin C supplement |
| Aspiration of food | None |
| Assessment using World Health Organization Disability Assessment Schedule 2.0 | None |
| Astringent agent | None |
| Asymmetric crying face association | None |
| Asymptomatic bacteriuria in pregnancy with postnatal complication | Asymptomatic bacteriuria in pregnancy |
| Atrial fistulography with venous access with contrast | None |
| Attachment avoidant | None |
| Auditory meatogram | None |
| Augmentation genioplasty with graft and implant | None |
| Autologous bone transplant | None |
| Autonomous attachment | None |
| Autosomal dominant familial isolated hypoparathyroidism | None |
| Autosomal recessive familial isolated hypoparathyroidism | None |
| Azole antifungal agent | None |
| Baby female | None |
| Baby male | None |
| Balloon angioplasty of renal artery | None |
| Barbiturate anticonvulsant agent | None |
| Battered husband | Victim of intimate partner abuse |
| Battered husband – history | History of victim of intimate partner abuse |
| Battered spouse syndrome | Victim of intimate partner abuse |
| Battered wife | Victim of intimate partner abuse |
| Battered wife – history | History of victim of intimate partner abuse |
| Benign childhood epilepsy with centrotemporal spikes, non-refractory | Self-limited epilepsy with centrotemporal spikes |
| Benign childhood epilepsy with centrotemporal spikes, refractory | None |
| Benign essential hypertension complicating pregnancy, childbirth and the puerperium with postnatal complication | Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
| Benign frontal epilepsy of childhood | Frontal lobe epilepsy |
| Benign mucous membrane pemphigoid with no eye involvement | None |
| Benign neoplasm of ventral surface of tongue | None |
| Benign paroxysmal positional vertigo nystagmus | Nystagmus due to benign paroxysmal positional vertigo |
| Benign paroxysmal positional vertigo or nystagmus | None |
| Benign psychomotor epilepsy of childhood | Self-limited focal epilepsy |
| Beta-lactam antibacterial agent | None |
| Beta-lactamase inhibitor antibacterial agent | None |
| Bicornuate uterus affecting obstetric care | Bicornuate uterus in pregnancy, childbirth and the puerperium |
| Biguanide antimalarial agent | None |
| Bilateral bronchography | None |
| Bilateral gouty tophus of elbows | None |
| Bilateral gouty tophus of hands | None |
| Bilateral traumatic amputation of legs at any level without complication | Bilateral traumatic amputation of lower limbs |
| Biliary tract transplantation | None |
| Bimonthly | None |
| Biotin supplement agent | Biotin supplement |
| Blind or low vision – both eyes | None |
| Blood pooling imaging agent | None |
| Blood smear specimen | None |
| Blood/tissue storage/culture container | None |
| Body position for tube feeding of patient | Body position for tube feeding |
| Boerema repair of hiatus hernia | None |
| Bone density study, dual photon absorptiometry | Dual energy X-ray absorptiometry |
| Bone imaging agent | None |
| Bone marrow imaging agent | None |
| Bone tumor/metastasis irradiation | None |
| Boron supplement agent | Boron supplement |
| Bowel cleanser agent | None |
| Bowel imaging for ectopic gastric mucosa | Radionuclide imaging of small intestine for Meckel diverticulum |
| Bowel imaging for Meckel’s diverticulum | Radionuclide imaging of small intestine for Meckel diverticulum |
| Brain imaging agent | None |
| Brazilian pemphigus foliaceus | Endemic pemphigus foliaceus |
| Breast engorgement in pregnancy, the puerperium or lactation with antenatal complication | Breast engorgement in pregnancy, the puerperium r lactation |
| Breech presentation with antenatal problem | Breech presentation |
| Brenner tumor of ovary | None |
| Broad spectrum penicillin antibacterial agent | None |
| Broken tooth with complication | Fracture of tooth |
| Broken tooth without complication | Fracture of tooth |
| Bronchodilator agent | Bronchodilator |
| Bronchus transplantation | None |
| Bypass graft mechanical complications | Complication of bypass graft |
| Calcium supplement agent | Calcium supplement |
| Candida duobushaemulonis | None |
| Candida sphaerica | None |
| Cannula procedure | None |
| Cannula, tube AND/OR catheter | None |
| Cannulation of vascular fistula, graft or prosthetic device | None |
| Carbuncle/furuncle | None |
| Carcinoma in situ of anterior two-thirds of tongue – ventral surface | None |
| Carcinoma ventral surface of tongue | None |
| Cardiac shunt study | None |
| Cardioplegia perfusion solution | Cardioplegic solution agent |
| Cardioplegia solution | Cardioplegic solution agent |
| Cardiovascular system transplantation | None |
| Caregiver able to cope | Caregiver able to cope |
| Caregiver can no longer cope | Caregiver unable to cope |
| Caregiver unable to cope | Caregiver unable to cope |
| Caretaking/parenting skills case management | None |
| Caretaking/parenting skills education, guidance, and counseling | None |
| Caretaking/parenting skills surveillance | None |
| Caretaking/parenting skills treatments and procedures | None |
| Catheter cholangiogram | None |
| Catheter cholecystogram | None |
| Catheter procedure | None |
| Cation exchange resin agent | Cation exchange resin |
| Central stimulant | Central stimulant |
| Central zone of prostate | None |
| Centrally acting antiobesity agent | None |
| Centrally acting hypotensive agent | Centrally acting hypotensive agent |
| Centrally acting muscle relaxant | Centrally acting muscle relaxant |
| Centrally inserted central venous catheter | None |
| Cephalosporin antibacterial agent | None |
| Cerebral ventriculography, air contrast | None |
| Cerebral ventriculography, positive contrast | None |
| Ceruminolytic agent | None |
| Cervical esophagram | None |
| Cervical incompetence with antenatal problem | Cervical incompetence |
| Cervical incompetence with postnatal complication | Cervical incompetence |
| Cervical myelography | None |
| Cesarean wound disruption with postnatal complication | Cesarean wound disruption |
| Chem. metabolic function tests | Metabolic function test |
| Chest clear | None |
| Chest wall fistulography with contrast | None |
| Chest wall, pleura and diaphragm operations | None |
| Chickenpox with complication | Varicella |
| Childhood epilepsy with occipital paroxysms | Occipital lobe epilepsy |
| Choanogram | None |
| Cholangiogram normal | Fluoroscopic cholangiography with contrast normal |
| Cholangiogram normal post-cholecystectomy | Postoperative fluoroscopic cholangiography with contrast normal |
| Cholangiogram normal post-sphincterotomy | Postoperative fluoroscopic cholangiography with contrast normal |
| Cholangiography | None |
| Cholecystectomy and operative cholangiogram | Cholecystectomy with intraoperative fluoroscopic cholangiography with contrast |
| Cholecystectomy with exploration of common duct with cholangiography | Cholecystectomy and exploration of common bile duct with intraoperative fluoroscopic cholangiography with contrast |
| Cholecystocholangiogram | Percutaneous transhepatic fluoroscopic cholecystocholangiography with contrast |
| Cholecystography | None |
| Choledochotomy and radiography | None |
| Cholesteatoma pearl | None |
| Chromium supplement agent | Chromium supplement |
| Chronic drug abuse | None |
| Chronic interstitial cystitis | Chronic primary bladder pain syndrome |
| Chronic peripheral venous hypertension with lower extremity complication | Chronic peripheral venous hypertension |
| Chronic pulmonary fibrosis caused by chemical vapors | None |
| Circumpapillary dystrophy of choroid | None |
| Cobalt supplement agent | Cobalt supplement |
| Coil/whorled fibers | None |
| Colorectal imaging agent | None |
| Colporrhaphy for repair of enterocele | None |
| Combined radiotherapy | None |
| Complement and immunoglobulin measurement | Complement assay |
| Complement assay, total | Complement assay |
| Complement C3 fragment measurement | None |
| Complement C3b-C4b receptor measurement | None |
| Complement C3d-C3d+GG-IC3b receptors measurement | None |
| Complement clr2-cls2 measurement | None |
| Complement component assay | Complement assay |
| Complement component, activity measurement | Complement assay |
| Complement component, antigen measurement | Complement assay |
| Complement protein measurement | Complement assay |
| Complete induced termination of pregnancy with complication | Complete induced termination of pregnancy |
| Complication of obstetrical surgery AND/OR procedure | Disorder following obstetric procedure |
| Congenital abnormality of uterus affecting obstetric care | Congenital abnormality of uterus in pregnancy, childbirth and the puerperium |
| Congenital glucose-galactose malabsorption | None |
| Congenital or acquired abnormality of vagina in pregnancy, childbirth and the puerperium | None |
| Contraceptive agent | None |
| Contrast amniography | None |
| Contrast bronchogram | None |
| Contrast dacryocystogram | None |
| Contrast media | Contrast media |
| Contrast procedure of cavity of the head | None |
| Contrast radiography of nasolacrimal ducts | None |
| Contrast sialogram | None |
| Contrast ventriculography of brain | None |
| Copper supplement agent | Copper supplement |
| Coronary arteriosclerosis after percutaneous coronary angioplasty | None |
| Coronary vasodilator | Vasodilator |
| Corpora cavernosography | None |
| Cracked nipple in pregnancy, the puerperium or lactation with antenatal complication | Cracked nipple in pregnancy, the puerperium or lactation |
| Cracked nipple in pregnancy, the puerperium or lactation with postnatal complication | Cracked nipple in pregnancy, the puerperium or lactation |
| CT sialogram | None |
| CT submandibular sialogram | None |
| Cyanocobalamin supplement agent | Vitamin B12 supplement |
| Cyclic lipopeptide antibacterial agent | None |
| Cycloplegic preparation | None |
| Cystocele affecting obstetric care | Cystocele in pregnancy, childbirth and the puerperium |
| Cytarabine 100 mg and daunorubicin 44 mg powder for solution for infusion vial | Cytarabine liposome 100 mg and daunorubicin liposome 44 mg powder for solution for infusion vial |
| Cytopathology procedure or service | Cytopathology procedure |
| Cytotoxic agent | Cytotoxic |
| Cytotoxic antibiotics | None |
| Dacryocystography | None |
| Decongestant agent | Decongestant |
| Decrease in size since previous mammogram | Decrease in size of lesion of breast since previous mammogram |
| Deep transverse arrest with antenatal problem | Deep transverse arrest |
| Degeneration of cervicothoracic intervertebral disc | None |
| Degree elevation of head of bed for tube feeding of patient | Degree elevation of head of bed for tube feeding |
| Delayed delivery second twin with antenatal problem | Delayed delivery of second twin |
| Delayed hypersensitivity skin test antigen | None |
| Delivered by cesarean delivery following previous cesarean delivery | None |
| Dento-oculocutaneous syndrome | None |
| Dependence on corticoids | None |
| Dependent drug abuse | None |
| Deposition of sodium urate crystals with inflammatory morphology | Deposition of monosodium urate crystals with inflammatory morphology |
| Dermodental dysplasia | None |
| Derodidymis | None |
| Diabetes mellitus without complication | Diabetes mellitus |
| Diagnostic aid | Diagnostic substance |
| Diagnostic dye preparation used in the eye | Diagnostic dye |
| Diagnostic dye-containing product | Diagnostic dye |
| Diagnostic eye preparations | None |
| Diagnostic radiography of upper gastrointestinal tract with serial films | None |
| Diagnostic radiography with contrast media by injection, positive contrast | None |
| Diagnostic radiography with gas-air, negative contrast | Plain X-ray with negative contrast |
| Diagnostic radiography with oral contrast | None |
| Diagnostic radioisotope | Radioactive isotope |
| Diagnostic radiologic examination with fluoroscopy | None |
| Diagnostic radiologic examination with fluoroscopy of chest | None |
| Diffuse large B-cell lymphoma (nodal/systemic with skin involvement) | Diffuse large B-cell lymphoma |
| Digestant | Digestant |
| Digestant agent | Digestant |
| Digestive proteinuria | None |
| Dilation of mature percutaneous transhepatic biliary drainage tract under radiological guidance | Fluoroscopy guided dilation of mature percutaneous transhepatic biliary drainage tract |
| Dilation/incision of cervix – delivery aid | None |
| Diphonia | None |
| Direct puncture operative cholangiography | Intraoperative fluoroscopic cholangiography by direct puncture with contrast |
| Disease of respiratory system complicating pregnancy | Disorder of respiratory system |
| Disinfectant dye | Disinfectant dye |
| Disinfectant soap | Disinfectant |
| Disodium 3,6-endoxohexahydrophthalate | None |
| Disorder due to alcohol abuse | None |
| Disorders of musculoskeletal implants and repairs | None |
| Disproportion – major pelvic abnormality with antenatal problem | Disproportion – major pelvic abnormality |
| Dissection of distal aorta | None |
| Dissociative convulsions | Focal onset epileptic seizure |
| Distant bone transplantation | None |
| Distressing present pain | None |
| Diuretic agent | Diuretic |
| Diverticulitis of large intestine with complication | Diverticulitis of large intestine |
| Diverticulitis of small intestine with complication | Diverticulitis of small intestine |
| Division of urinary tract | None |
| Do not turn patient | Turning patient contraindicated |
| Dominant attachment | None |
| Drowning and non-fatal immersion | None |
| Drug abuse | None |
| Drug abuse in remission | Harmful pattern of substance use in remission |
| Drug abuse prevention | None |
| Drug abuse prevention assessment | None |
| Drug abuse prevention education | None |
| Drug abuse prevention management | None |
| Drug abuse, continuous | None |
| Drug habituation | None |
| Drugs used in migraine prophylaxis | None |
| Drugs used in neuropathic pain | None |
| Dual energy X-ray absorptiometry of lumbar spine | None |
| Dual energy X-ray photon absorptiometry of wrist | None |
| Duodenum double contrast examination | None |
| Echinocandin antifungal agent | None |
| Echocardiographic contrast media | Contrast media |
| Eclampsia with postnatal complication | Eclampsia |
| Elastoplast mold | None |
| Elderly primigravida with antenatal problem | Elderly primigravida |
| Embolism superior longitudinal sinus | None |
| Emetic agent | Emetic |
| Emollient agent | Emollient |
| Endarterectomy of aorta with patch graft | None |
| Endocrine and exocrine imaging agent | None |
| Endocrine imaging agent | None |
| Endoscopic operation | Endoscopic procedure |
| Endoscopic ureter biopsy | None |
| Endotracheal bronchography | None |
| Endovascular repair of aneurysm of iliac artery with graft using radiologic guidance | Fluoroscopy guided endovascular repair of aneurysm of iliac artery using stent graft with contrast |
| Enmeshed attachment | None |
| Enteral hyperalimentation | Enteral feeding |
| Entire anal sinus | None |
| Entire femur | None |
| Entire innermost glandular zone of prostate | None |
| Entire internal glandular zone of prostate | None |
| Entire left intrahepatic bile duct branches | None |
| Entire lining of anal canal | None |
| Entire monostomatic sublingual gland | Entire sublingual gland |
| Entire mucosa of surface of tongue | None |
| Entire nasopharyngeal gland | None |
| Entire palatine portion of dorsum of tongue | None |
| Entire polystomatic sublingual gland | Entire sublingual gland |
| Entire right intrahepatic bile duct branches | None |
| Entire specialization of anal canal | None |
| Entire structure of lateral part of body of tongue | None |
| Entire undescended left testis | Undescended left testicle |
| Entire undescended right testis | Undescended right testicle |
| Entire undescended testis | Undescended testicle |
| Entire vitellointestinal structure | None |
| Epidermal growth factor receptor antagonist antineoplastic agent | None |
| Epididymis transplantation | None |
| Epidurogram | Fluoroscopy of epidural space with contrast |
| Episodic drug abuse | Episodic harmful pattern of substance use |
| Erythema multiforme-like lupus erythematosus | None |
| Excessive amount of blood / fluid infusion | None |
| Excessive amount of blood / fluid transfusion | None |
| Excision of bilateral breasts for female to male transsexual | Excision of bilateral breasts |
| Excision of tendon for graft | None |
| Excision of tendon of hand for graft | None |
| Excision of tissue or organ for grafting from donor site | Harvesting of donor material |
| Excruciating present pain | None |
| Exercise-induced asthma | Exercise induced bronchospasm |
| Expectorant agent | None |
| Exposure to nongonococcal urethritis | Exposure to infective urethritis |
| Extended spectrum penicillin antibacterial agent | None |
| External ear transplantation | None |
| Extra-abdominal fibromatosis | Aggressive fibromatosis |
| Extratemporal epilepsy | Focal epilepsy |
| Facial bone transplantation | None |
| Factor B complement assay | None |
| Failed cholangiogram | Failed fluoroscopic cholangiography with contrast |
| Failed mechanical induction with antenatal problem | Failed mechanical induction |
| Failure of lactation with antenatal complication | Failure of lactation |
| Failure of lactation with postnatal complication | Failure of lactation |
| Fall – collision/push/shove | None |
| Familial neonatal seizures | Self-limited familial neonatal epilepsy |
| Family history of diabetes mellitus with complication | Family history of diabetes mellitus |
| Fatigue during pregnancy with postnatal complication | Fatigue during pregnancy |
| Feature of present pain intensity | None |
| Feature of sex of baby | None |
| Feeding and dietary regime | None |
| Female genital system contrast procedure | None |
| Fetal distress with antenatal problem | Nonreassuring fetal status |
| Fetography | None |
| Fetus with chromosomal abnormality with antenatal problem | Fetus with chromosomal abnormality |
| Fetus with damage due to intrauterine contraceptive device with antenatal problem | Fetus with damage due to intrauterine contraceptive device |
| Fetus with drug damage with antenatal problem | Fetus with drug damage |
| Fetus with hereditary disease with antenatal problem | Fetus with hereditary disease |
| Fetus with viral damage via mother with antenatal problem | Fetus with viral damage via mother |
| FH: Bronchitis/COAD | None |
| Fiberoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | None |
| Fibrocalculous pancreatopathy without complication | Fibrocalculous pancreatic diabetes |
| Finances education, guidance, and counseling | None |
| Finding of present pain intensity | None |
| Finding of sex of baby | None |
| First degree perineal tear during delivery with postnatal problem | First degree perineal laceration |
| First generation cephalosporin antibacterial agent | None |
| Fistulography of abdominal wall with contrast | None |
| Fistulography of anal fistula | None |
| Fistulography with contrast | None |
| Fluoride supplement agent | Fluoride supplement |
| Fluoroquinolone antibacterial agent | None |
| Fluoroscopic pouchography | Fluoroscopy of ileal pouch with contrast |
| Fluoroscopy – skeleton/limbs | None |
| Fluoroscopy and radiography | None |
| Fluoroscopy and radiography – brain | Fluoroscopy – brain |
| Fluoroscopy and radiography – cervical column | None |
| Fluoroscopy and radiography – chest wall | None |
| Fluoroscopy and radiography – digestive | Digestive system fluoroscopy |
| Fluoroscopy and radiography – female genital | None |
| Fluoroscopy and radiography – lungs | None |
| Fluoroscopy and radiography – skeleton | None |
| Fluoroscopy and radiography – skull | None |
| Fluoroscopy and radiography – urinary | None |
| Fluoroscopy guided angioplasty of abdominal aorta with contrast | None |
| Fluoroscopy guided angioplasty of aorta with contrast | None |
| Fluoroscopy guided angioplasty of arteriovenous fistula with contrast | None |
| Fluoroscopy guided angioplasty of artery with contrast | None |
| Fluoroscopy guided angioplasty of bilateral renal arteries with contrast | None |
| Fluoroscopy guided angioplasty of brachial artery with contrast | None |
| Fluoroscopy guided angioplasty of carotid artery with contrast | None |
| Fluoroscopy guided angioplasty of celiac artery with contrast | None |
| Fluoroscopy guided angioplasty of common carotid artery with contrast | None |
| Fluoroscopy guided angioplasty of common femoral artery with contrast | None |
| Fluoroscopy guided angioplasty of coronary artery with contrast | None |
| Fluoroscopy guided angioplasty of external carotid artery with contrast | None |
| Fluoroscopy guided angioplasty of femoral artery with contrast | None |
| Fluoroscopy guided angioplasty of hepatic artery with contrast | None |
| Fluoroscopy guided angioplasty of iliac artery with contrast | None |
| Fluoroscopy guided angioplasty of inferior mesenteric artery with contrast | None |
| Fluoroscopy guided angioplasty of internal carotid artery with contrast | None |
| Fluoroscopy guided angioplasty of lower limb artery with contrast | None |
| Fluoroscopy guided angioplasty of mesenteric artery with contrast | None |
| Fluoroscopy guided angioplasty of popliteal artery with contrast | None |
| Fluoroscopy guided angioplasty of profunda femoris with contrast | None |
| Fluoroscopy guided angioplasty of renal artery with contrast | None |
| Fluoroscopy guided angioplasty of renal transplant with contrast | None |
| Fluoroscopy guided angioplasty of right renal artery with contrast | None |
| Fluoroscopy guided angioplasty of splenic artery with contrast | None |
| Fluoroscopy guided angioplasty of subclavian artery with contrast | None |
| Fluoroscopy guided angioplasty of superficial femoral artery with contrast | None |
| Fluoroscopy guided angioplasty of superior mesenteric artery with contrast | None |
| Fluoroscopy guided angioplasty of superior vena cava with contrast | None |
| Fluoroscopy guided angioplasty of tibial artery with contrast | None |
| Fluoroscopy guided angioplasty of vertebral artery with contrast | None |
| Fluoroscopy guided angioplasty with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of anterior tibial artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of celiac artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of external iliac artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of hepatic artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of posterior tibial artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of pulmonary artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of renal artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of subclavian artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of superior mesenteric artery with contrast | None |
| Fluoroscopy guided percutaneous transluminal angioplasty of vein with contrast | None |
| Fluoroscopy guided venoplasty with contrast | None |
| Foley catheter long term use | None |
| Folic acid supplement agent | Folate supplement |
| Follicular center B-cell lymphoma (nodal/systemic with skin involvement) | Malignant lymphoma, follicular center cell |
| Fourth generation cephalosporin antibacterial agent | None |
| Fremitus | None |
| Functional disorder of stomach | None |
| Fusion by stapling | None |
| Galactorrhea in pregnancy and the puerperium with antenatal complication | Galactorrhea in pregnancy and the puerperium |
| Galactorrhea in pregnancy and the puerperium with postnatal complication | Galactorrhea in pregnancy and the puerperium |
| Gallbladder transplantation | None |
| Gastric mucosa imaging | None |
| Gastroesophageal reflux study, radiographic | None |
| Gastrointestinal tract transplantation | None |
| Gender confirmation bottom surgery | Surgical procedure |
| Gender confirmation surgery | Surgical procedure |
| Gender confirmation top surgery | Operation on breast |
| General body state finding | Clinical finding |
| General clinical state finding | Clinical finding |
| Generally contracted pelvis with antenatal problem | Contracted pelvis |
| Genitourinary tract infection in pregnancy with postnatal complication | Genitourinary tract infection in pregnancy |
| Glucocorticoid hormone | None |
| Glycopeptide antibacterial agent | None |
| Glycosuria during pregnancy with postnatal complication | Pregnancy-related glycosuria |
| Gonorrhea with local complication | Gonorrhea |
| Gouty arthropathy | None |
| Gouty tophus of left foot | None |
| Graft complications | None |
| Grafting of tendon of hand | None |
| Grand multiparity with antenatal problem | Grand multipara |
| Gynecogram | None |
| Hair transplant | None |
| Hallucinogen | Hallucinogenic agent |
| Hand tendon excised for graft | None |
| Harmful use of anxiolytic | None |
| Harmful use of hypnotic | None |
| Harmful use of ketamine | None |
| Head fistulography with contrast | None |
| Healthcare needs met by service | None |
| Heart and cardiovascular imaging agent | None |
| Hematuria co-occurrent and due to chronic interstitial cystitis | None |
| Hemorrhoid preparation | None |
| Hemorrhoids without complication | Hemorrhoids |
| Hemostatic agent | Hemostatic agent |
| Hepatobiliary imaging agent | None |
| Herpes zoster with nervous system complication | Herpes zoster |
| Herpes zoster without complication | Herpes zoster |
| High head at term with antenatal problem | High head at term |
| Hiletron neutron external beam radiation therapy | Deuterium on tritium neutron external beam radiation therapy |
| Hip joint transplantation | None |
| History of alcohol abuse | History of alcohol use disorder |
| History of drug abuse | History of substance use disorder |
| History of gender confirmation surgery | History of surgery |
| History of substance abuse | History of substance use disorder |
| Hoover’s sign | None |
| Horrible present pain | None |
| Housing education, guidance, and counseling | None |
| Human tissue collagen dermal filler | Skin fillers and protectives |
| Hydrocephalic disproportion with antenatal problem | Hydrocephalic disproportion |
| Hyperimmunoglobulin E syndrome | None |
| Hypertonic uterine inertia with antenatal problem | Hypertonic uterine inertia |
| Hypnotic agent | Hypnotic agent |
| Hypnotic withdrawal without complication | Hypnotic withdrawal |
| Hypoglycemic agent | None |
| Hypotensive agent | Hypotensive agent |
| Hypotonic duodenography | Fluoroscopic hypotonic duodenography |
| Hysterogram | Fluoroscopic hysterography with contrast |
| Hysterosalpingogram abnormal | Fluoroscopic hysterosalpingography with contrast abnormal |
| Hysterosalpingogram normal | Fluoroscopic hysterosalpingography with contrast normal |
| Hysterosalpingogram requested | Fluoroscopic hysterosalpingography with contrast requested |
| Hysterosalpingography | Fluoroscopic hysterosalpingography with contrast |
| Hysterosalpingography with gas contrast | Fluoroscopic hysterosalpingography with contrast |
| Imaging agent | None |
| Imidazole antifungal agent | None |
| Immune enhancement agent | Immune enhancement agent |
| Immune system transplantation | None |
| Immunosuppressant agent | Immunosuppressant |
| Immunotherapeutic agent | Immunologic agent |
| In care | None |
| Incomplete miscarriage with complication | Incomplete miscarriage |
| Increase in size since previous mammogram | Increase in size of lesion of breast since previous mammogram |
| Indrawing of ribs during respiration | None |
| Infarct of cerebrum due to iatrogenic cerebrovascular accident | None |
| Infection and inflammation imaging agent | None |
| Inflammatory bowel disease drug | None |
| Inguinal herniorrhaphy using darn | None |
| Inlet pelvic contraction with antenatal problem | Inlet contraction of pelvis |
| Inosine dimepranol acedoben | None |
| Inotropic agent | Inotropic agent |
| Insecticide agent | Insecticide |
| Insertion of brachytherapy device | None |
| Insertion of central venous catheter | None |
| Insertion of laminaria into vagina | Insertion of laminaria into cervix |
| Insertion of percutaneous gastrojejunostomy tube using radiologic guidance | Fluoroscopy guided insertion of percutaneous gastrojejunostomy tube |
| Insertion of prosthesis or prosthetic device of chin, polyethylene or silastic | None |
| Insertion of silicone implant for correction of pectus excavatum | None |
| Internal metabolic radiotherapy | None |
| Intra-arterial digital subtraction angiography | Fluoroscopic intra-arterial digital subtraction angiography with contrast |
| Intracavitary brachytherapy of female genital tract | None |
| Intracavitary X-ray therapy | None |
| Intractable complex partial parietal lobe epilepsy | None |
| Intractable idiopathic partial epilepsy | None |
| Intraoperative cholangiography | Intraoperative fluoroscopic cholangiography with contrast |
| Intraoperative cholangiography guided laparoscopic biopsy of bile duct with contrast | Intraoperative fluoroscopic cholangiography guided laparoscopic biopsy of bile duct with contrast |
| Intraoperative transhepatic cholangiography | Intraoperative percutaneous transhepatic fluoroscopic cholangiography with contrast |
| Intrauterine death with antenatal problem | None |
| Intravenous cholangiography | None |
| Intravenous cholecystography | None |
| Intravenous digital subtraction angiography | Fluoroscopic intravenous digital subtraction angiography with contrast |
| Intravenous digital subtraction angiography of cervicocerebral arteries | Fluoroscopic intravenous digital subtraction angiography of cervicocerebral arteries with contrast |
| Intravenous fluids and electrolytes | None |
| Intravenous pyelogram with KUB | None |
| Iodine supplement agent | Iodine supplement |
| Ion exchange resin agent | Ion exchange resin |
| Iridium wire therapy | None |
| Iron supplement agent | Iron supplement |
| Irritant | Irritant |
| Islands in region of Spain | None |
| Isotope static placentography | None |
| Jacksonian, focal or motor epilepsy | Primary motor cortex frontal lobe epilepsy |
| Karathane | Meptyldinocap |
| Keratolytic agent | None |
| Kidney imaging agent | None |
| Klatskin’s tumor | Cholangiocarcinoma |
| Klatskin’s tumor | Perihilar cholangiocarcinoma |
| Labile personality trait | None |
| Lack of social support | None |
| Lamellar ichthyosis AND trichorrhexis invaginata syndrome | None |
| Laparoscopic cholecystectomy with cholangiography | Laparoscopic cholecystectomy with intraoperative fluoroscopic cholangiography with contrast |
| Laparoscopic intraoperative cholangiography with contrast | Laparoscopic intraoperative fluoroscopic cholangiography with contrast |
| Laparoscopic percutaneous transhepatic cholangiography with contrast | Laparoscopic percutaneous transhepatic fluoroscopic cholangiography with contrast |
| Laparoscopic repair of bilateral direct inguinal hernias with graft or prosthesis | None |
| Laparoscopic repair of bilateral indirect inguinal hernias with graft or prosthesis | None |
| Laparoscopic repair of bilateral inguinal hernias with prosthesis or graft | None |
| Laparoscopic repair of bilateral, one direct and one indirect, inguinal hernias with graft or prosthesis | None |
| Laparoscopic repair of recurrent umbilical hernia using sutures with fascial closure | None |
| Laparoscopic repair of umbilical hernia using sutures with fascial closure | None |
| Laparoscopic supracervical hysterectomy | None |
| Large fetus causing disproportion with antenatal problem | None |
| Laser cycloablation | None |
| Latent convergent squint | None |
| Latent divergent squint | None |
| Latent vertical squint | None |
| Latent vertical squint with eye down | None |
| Latent vertical squint with eye up | None |
| Laxative agent | Laxative |
| Lead antiinfective agent | None |
| Left intrahepatic bile duct branches | None |
| Ligation of major artery of abdomen | None |
| Ligation of major artery of chest | None |
| Ligation of major artery of extremity | None |
| Ligation of major artery of neck | None |
| Linear accelerator electron external beam radiation therapy | None |
| Linear accelerator electrons | None |
| Linear accelerator photon therapy | None |
| Lining of anal canal | None |
| Liver and spleen imaging agent | None |
| Liver transplant without recipient hepatectomy | None |
| Lobectomy of liver with partial excision of adjacent lobes | None |
| Local anesthetic nerve block of penis | None |
| Local bone transplantation | None |
| Localization-related cryptogenic epilepsy | Focal epilepsy |
| Localization-related idiopathic epilepsy | Focal epilepsy |
| Localization-related symptomatic epilepsy | Focal epilepsy |
| Localization-related symptomatic epilepsy with specific precipitant | Focal epilepsy |
| Loop diuretic agent | Loop diuretic |
| Lubricant agent | Lubricant |
| Lumbar DXA scan result normal | None |
| Lumbosacral myelography | None |
| Lumbosacral plexopathy due to and following procedure caused by ionizing radiation | None |
| Lung imaging agent | None |
| Lung perfusion imaging agent | None |
| Lung ventilation imaging agent | None |
| Lymphatic system imaging agent | None |
| Lymphoplasmacytic B-cell lymphoma, nodal/systemic with skin involvement | Malignant lymphoma – lymphoplasmacytic |
| Macrolide antibacterial agent | None |
| Macromolecular blood substitute | Macromolecular blood substitute |
| Magnesium supplement agent | Magnesium supplement |
| Magnetic resonance imaging contrast media | Magnetic resonance imaging contrast media |
| Major histocompatibility complex class I deficiency | None |
| Malignant neoplasm of lateral border of tongue | None |
| Malnutrition-related diabetes mellitus with peripheral circulatory complications | Peripheral circulatory disorder due to malnutrition-related diabetes mellitus |
| Malnutrition-related diabetes mellitus with renal complications | Malnutrition related diabetes mellitus |
| Malnutrition-related diabetes mellitus without complications | Malnutrition related diabetes mellitus |
| Manganese supplement agent | Manganese supplement |
| Mantle cell B-cell lymphoma (nodal/systemic with skin involvement) | Mantle cell lymphoma |
| Maternal distress with antenatal problem | Maternal distress |
| Maternal distress with postnatal problem | Maternal distress |
| Maternal hypotension syndrome with antenatal problem | Maternal hypotension syndrome |
| Maternal hypotension syndrome with postnatal problem | Maternal hypotension syndrome |
| Maternal tobacco abuse | None |
| Measles with complication | Measles |
| Mechanical complication associated with orthopedic device | Complication associated with orthopedic device |
| Mechanical complication due to cardiac pacemaker electrode | Disorder of cardiac pacemaker electrode |
| Mechanical complication due to corneal graft | Complication following transplant of cornea |
| Mechanical complication due to coronary bypass graft | None |
| Mechanical complication due to skin graft failure AND/OR rejection | Disorder following skin grafting procedure |
| Mechanical complication of aortic graft | Disorder of vascular graft |
| Mechanical complication of arteriovenous access or graft | Disorder of arteriovenous graft |
| Mechanical complication of arteriovenous surgical fistula | Disorder of surgical arteriovenous fistula |
| Mechanical complication of arteriovenous surgical shunt | Disorder of arteriovenous shunt |
| Mechanical complication of bile duct prosthesis | Disorder of bile duct prosthesis |
| Mechanical complication of bone graft | Disorder of bone graft |
| Mechanical complication of breast prosthesis | Disorder of breast implant |
| Mechanical complication of cardiac implant | Complication associated with cardiac implant |
| Mechanical complication of cardiac pacemaker | Disorder of cardiac pacemaker system |
| Mechanical complication of cardiovascular device | Complication associated with device |
| Mechanical complication of carotid artery bypass | None |
| Mechanical complication of carotid artery bypass graft | None |
| Mechanical complication of cartilage graft | Disorder of cartilage graft |
| Mechanical complication of central nervous system device | Complication associated with neurological device |
| Mechanical complication of central venous catheter | None |
| Mechanical complication of chin prosthesis | Complication of internal prosthetic device |
| Mechanical complication of colostomy | Complication of colostomy |
| Mechanical complication of coronary bypass | None |
| Mechanical complication of cystostomy catheter | Disorder of cystostomy catheter |
| Mechanical complication of device | Complication associated with device |
| Mechanical complication of dialysis catheter | Complication associated with dialysis catheter |
| Mechanical complication of dorsal column stimulator | Disorder of dorsal column stimulator |
| Mechanical complication of electrodes implanted in brain | Disorder of electrodes implanted in brain |
| Mechanical complication of enterostomy | Disorder of stoma |
| Mechanical complication of esophagostomy | Disorder of stoma |
| Mechanical complication of eye orbit prosthesis | Disorders of prostheses and implants of the eye |
| Mechanical complication of gastrointestinal prosthetic device | Complication associated with device |
| Mechanical complication of gastrostomy | Disorder of stoma |
| Mechanical complication of genitourinary device | Disorder associated with urogenital device |
| Mechanical complication of heart valve prosthesis | Disorder of prosthetic cardiac valve |
| Mechanical complication of hemodialysis catheter | Complication of intravascular line |
| Mechanical complication of implant | Complication of implant |
| Mechanical complication of internal fixation device | Complication of internal fixation device |
| Mechanical complication of internal joint prosthesis | Disorder of prosthetic joint |
| Mechanical complication of internal nail fixing device | Complication of internal fixation device |
| Mechanical complication of internal orthopedic device | Complication of internal fixation device |
| Mechanical complication of internal plate fixing device | Complication of internal fixation device |
| Mechanical complication of internal rod fixation device | Complication of internal fixation device |
| Mechanical complication of intra-aortic balloon | Disorder of intra-aortic pulsation balloon |
| Mechanical complication of intra-aortic balloon device | Disorder of intra-aortic pulsation balloon |
| Mechanical complication of intraocular lens | Disorder of intraocular lens |
| Mechanical complication of intrauterine contraceptive device | Disorder of intrauterine contraceptive device |
| Mechanical complication of muscle graft | Disorder of muscle graft |
| Mechanical complication of musculoskeletal implant | Complication associated with musculoskeletal implant |
| Mechanical complication of nervous system device | Complication associated with neurological device |
| Mechanical complication of nervous system device, implant AND/OR graft | None |
| Mechanical complication of nervous system implant | Complication associated with nervous system implant |
| Mechanical complication of peripheral nerve graft | Disorder of peripheral nerve graft |
| Mechanical complication of peritoneal dialysis catheter | Disorder of peritoneal dialysis catheter |
| Mechanical complication of prosthetic reconstruction of vas deferens | Disorder of prosthetic reconstruction of vas deferens |
| Mechanical complication of suprapubic catheter | Disorder of cystostomy catheter |
| Mechanical complication of tendon graft | Disorder of tendon graft |
| Mechanical complication of tissue graft | None |
| Mechanical complication of ureter repair graft | Disorder of ureter repair graft |
| Mechanical complication of ureteric stent | Disorder associated with urogenital device |
| Mechanical complication of urethral catheter | Disorder of urethral catheter |
| Mechanical complication of urethral indwelling catheter | Disorder of urethral catheter |
| Mechanical complication of urethral stent | Disorder associated with urogenital device |
| Mechanical complication of urinary tract stent | Disorder associated with urogenital device |
| Mechanical complication of vascular device | Complication associated with vascular device |
| Mechanical complication of vascular implant | Complication associated with vascular implant |
| Mechanical complication of vena cava umbrella | Complication associated with vascular implant |
| Mechanical complication of venous catheter | Complication of intravascular line |
| Mechanical complication of ventilator | Complication associated with device |
| Mechanical complication of ventricular communicating shunt | Disorder of brain ventricular shunt |
| Medication action/side effects care | None |
| Medication action/side effects case management | None |
| Medication action/side effects education, guidance, and counseling | None |
| Medication action/side effects surveillance | None |
| Medicinal product categorized by therapeutic role | None |
| Megavoltage radiation therapy using photons | None |
| Mercurial diuretic agent | None |
| Mercury antiinfective agent | None |
| Metastatic carcinoma to ventral surface of tongue | None |
| Method of administration for tube feeding of patient | Method of administration for tube feeding |
| Metoidioplasty | Metoidioplasty |
| Micrognathus ensenadae | None |
| Mild present pain | None |
| Mineral supplement agent | Mineral supplement |
| Mineralocorticoid hormone | None |
| Miotic agent | Miotic |
| Missile | None |
| Missile injury | None |
| Mixed feto-pelvic disproportion with antenatal problem | Mixed feto-pelvic disproportion |
| Mold technique gamma/beta | None |
| Molybdenum supplement agent | Molybdenum supplement |
| Monobactam antibacterial agent | None |
| Monoclonal antibody antineoplastic agent | None |
| Monostomatic sublingual gland | Sublingual gland structure |
| Moschowitz enterocele repair | None |
| Motility stimulant | Motility stimulant |
| Motor epilepsy | None |
| Mouth transplantation | None |
| Movement radiography | None |
| Mucolytic agent | None |
| Mucosa of surface of tongue | None |
| Mucositis following radiation therapy | None |
| Multi-plane radionuclide tomography | None |
| Multiple gastrointestinal atresias | Autosomal recessive combined immunodeficiency with multiple intestinal atresias |
| Multiple open wounds of lower limb with complication | Multiple open wounds of lower limb |
| Multiple open wounds of upper limb with complication | Open wound of multiple sites of upper limb |
| Multiple open wounds with complication | Multiple open wounds |
| Multiple open wounds without complication | Multiple open wounds |
| Multiple pregnancy with malpresentation with antenatal problem | None |
| Multivitamin preparation | Multivitamin agent |
| Multivitamin+mineral preparations | Multivitamin multimineral supplement |
| Mumps without complication | Mumps |
| Muscle transplantation | None |
| Musculoskeletal system transplantation | None |
| Mydriatic agent | None |
| Myelogram of posterior fossa | None |
| Myelography of entire spinal canal | None |
| Myocardial imaging agent | None |
| Myocutaneoosseous transplantation | None |
| Myocutaneous transplantation | None |
| N-Acetyl-alpha-glucosaminidase | None |
| Naloxone dependence | None |
| Nasal flaring | None |
| Nasal or ocular or otic dose form | None |
| Nasal septum button | None |
| Natural penicillin antibacterial agent | None |
| Neck fistulography with contrast | None |
| Neck transplantation | None |
| Neglect or abandonment | None |
| Neuropathy due to type 1 diabetes mellitus | None |
| New attachment of nerve | None |
| Niacin supplement agent | Niacin supplement |
| Nissen fundoplication | None |
| Nitrofuran derivative antibacterial agent | None |
| Nitrogen mustard derivative antineoplastic agent | None |
| Nitrophenol antifungal agent | None |
| Nitrosurea antineoplastic agent | None |
| No alcohol abuse | No evidence of alcohol use disorder |
| No present pain | No pain |
| No substance abuse | No evidence of substance use disorder |
| Nocturnal epilepsy | Epilepsy |
| Non dependent drug abuse | Nondependent harmful pattern of substance use |
| Non-alcoholic fatty liver | Metabolic dysfunction-associated steatotic liver |
| Non-compliance of drug therapy | None |
| Nondependent antidepressant type drug abuse in remission | Nondependent harmful pattern of use of antidepressant in remission |
| Nondependent antidepressant type drug abuse, continuous | Continuous nondependent harmful pattern of use of antidepressant |
| Nondependent antidepressant type drug abuse, episodic | Episodic nondependent harmful pattern of use of antidepressant |
| Nondependent mixed drug abuse | Nondependent harmful pattern of mixed substance use |
| Nondependent mixed drug abuse in remission | Nondependent harmful pattern of mixed substance use in remission |
| Nondependent mixed drug abuse, continuous | Continuous nondependent harmful pattern of mixed substance use |
| Nondependent mixed drug abuse, episodic | Episodic nondependent harmful pattern of mixed substance use |
| Nongonococcal cervicitis | None |
| Non-steroidal anti-inflammatory agent | Non-steroidal anti-inflammatory agent |
| Normal birth | None |
| Nutrition / feeding management | None |
| Nutritional supplement | Nutritional supplement |
| Oblique lie with antenatal problem | Oblique lie |
| Obstetric air pulmonary embolism with antenatal complication | Obstetric air pulmonary embolism |
| Obstetric air pulmonary embolism with postnatal complication | Obstetric air pulmonary embolism |
| Obstetric anesthesia with cardiac complications with antenatal problem | Obstetric anesthesia with cardiac complications |
| Obstetric anesthesia with cardiac complications with postnatal problem | Obstetric anesthesia with cardiac complications |
| Obstetric anesthesia with central nervous system complication with antenatal problem | Obstetric anesthesia with central nervous system complications |
| Obstetric anesthesia with central nervous system complication with postnatal problem | Obstetric anesthesia with central nervous system complications |
| Obstetric blood-clot pulmonary embolism with antenatal complication | Obstetric pulmonary thromboembolism |
| Obstetric blood-clot pulmonary embolism with postnatal complication | Obstetric pulmonary thromboembolism |
| Obstetric breast abscess with antenatal complication | Obstetric abscess of breast |
| Obstetric breast abscess with postnatal complication | Obstetric abscess of breast |
| Obstetric damage to pelvic joints and ligaments with postnatal problem | Damage to pelvic joints AND/OR ligaments during delivery |
| Obstetric high vaginal laceration with postnatal problem | Obstetric high vaginal laceration |
| Obstetric laceration of cervix with postnatal problem | Laceration of cervix due to childbirth |
| Obstetric nipple infection with antenatal complication | Obstetric nipple infection |
| Obstetric nipple infection with postnatal complication | Obstetric nipple infection |
| Obstetric non-purulent mastitis with antenatal complication | Obstetric non-purulent mastitis |
| Obstetric non-purulent mastitis with postnatal complication | Obstetric non-purulent mastitis |
| Obstetric pelvic hematoma with postnatal problem | Pelvic hematoma during delivery |
| Obstetric perineal wound disruption with postnatal complication | Obstetric perineal wound disruption |
| Obstetric pyemic and septic pulmonary embolism with antenatal complication | Obstetric pyemic and septic pulmonary embolism |
| Obstetric pyemic and septic pulmonary embolism with postnatal complication | Obstetric pyemic and septic pulmonary embolism |
| Obstetric transplantation | None |
| Obstetrics incision | None |
| Obstructed labor caused by bony pelvis with antenatal problem | Obstructed labor caused by bony pelvis |
| Obstructed labor caused by pelvic soft tissues with antenatal problem | Obstructed labor caused by pelvic soft tissues |
| Obstructed labor due to fetal malposition with antenatal problem | Obstructed labor due to fetal malposition |
| Ocular or otic dose form | None |
| Oligoarticular osteoarthritis | None |
| Oligohydramnios with antenatal problem | Oligohydramnios |
| Omphalomesenteric duct contrast radiography | None |
| One male and one female baby | None |
| One male and two female babies | None |
| Open pancreatography | None |
| Open repair of recurrent incisional hernia of anterior abdominal wall using biological mesh with component separation | None |
| Open wound in mouth with complication | Open wound in mouth |
| Open wound of anterior abdominal wall with complication | Open wound of anterior abdominal wall |
| Open wound of anterior abdominal wall without complication | Open wound of anterior abdominal wall |
| Open wound of anterior neck with complication | Open wound of throat |
| Open wound of auricle of ear without complication | Open wound of external ear |
| Open wound of back with complication | Open wound of back |
| Open wound of back, uncomplicated | Open wound of back |
| Open wound of buccal mucosa without complication | Open wound of buccal mucosa |
| Open wound of cheek with complication | Open wound of cheek |
| Open wound of cheek without complication | Open wound of cheek |
| Open wound of chest wall with complication | Open wound of chest wall |
| Open wound of chest wall, uncomplicated | Open wound of chest wall |
| Open wound of ear drum with complication | Open wound of eardrum |
| Open wound of ear drum without complication | Open wound of eardrum |
| Open wound of ear with complication | Open wound of ear |
| Open wound of ear without complication | Open wound of ear |
| Open wound of epigastric region with complication | Open wound of epigastric region |
| Open wound of external ear with complication | Open wound of external ear |
| Open wound of external ear without complication | Open wound of external ear |
| Open wound of external genital organs with complication | Open wound of external genital organs |
| Open wound of external genital organs without complication | Open wound of external genital organs |
| Open wound of face with complication | Open wound of face |
| Open wound of face without complication | Open wound of face |
| Open wound of finger with complication | Open wound of finger |
| Open wound of flank with complication | Open wound of flank |
| Open wound of flank without complication | Open wound of flank |
| Open wound of floor of mouth without complication | Open wound of mouth floor |
| Open wound of foot with complication | Open wound of foot |
| Open wound of forehead with complication | Open wound of forehead |
| Open wound of forehead without complication | Open wound of forehead |
| Open wound of groin with complication | Open wound of inguinal region |
| Open wound of gum with complication | Open wound of gum |
| Open wound of hand with complication | Open wound of hand |
| Open wound of head with complication | Open wound of head |
| Open wound of head without complication | Open wound of head |
| Open wound of hip AND thigh with complication | None |
| Open wound of hip AND thigh without complication | None |
| Open wound of hip with complication | Open wound of hip region |
| Open wound of iliac region with complication | Open wound of inguinal region |
| Open wound of jaw with complication | Open wound of jaw |
| Open wound of jaw without complication | Open wound of jaw |
| Open wound of larynx and trachea with complication | Open wound of larynx and trachea |
| Open wound of larynx with complication | Open wound of larynx |
| Open wound of larynx without complication | Open wound of larynx |
| Open wound of lateral abdominal wall with complication | Open wound of lateral abdominal wall |
| Open wound of lip without complication | Open wound of lip |
| Open wound of lower limb with complication | Open wound of lower limb |
| Open wound of lower limb without complication | Open wound of lower limb |
| Open wound of mouth without complication | Open wound in mouth |
| Open wound of multiple sites of face with complication | Multiple open wounds of face |
| Open wound of multiple sites of face without complication | Multiple open wounds of face |
| Open wound of nasal cavity without complication | Open wound of nasal cavity |
| Open wound of neck with complication | Open wound of neck |
| Open wound of neck without complication | Open wound of neck |
| Open wound of nose with complication | Open wound of nose |
| Open wound of nose without complication | Open wound of nose |
| Open wound of palate with complication | Open wound of palate |
| Open wound of palate without complication | Open wound of palate |
| Open wound of pelvic region with complication | Open wound of pelvic region |
| Open wound of pelvic region without complication | Open wound of pelvic region |
| Open wound of perineum with complication | Open wound of perineum |
| Open wound of perineum without complication | Open wound of perineum |
| Open wound of pharynx with complication | Open wound of pharynx |
| Open wound of pharynx without complication | Open wound of pharynx |
| Open wound of scalp without complication | Open wound of scalp |
| Open wound of scrotum and testes with complication | Open wound of scrotum and testes |
| Open wound of scrotum with complication | Open wound of scrotum |
| Open wound of shoulder region with complication | Open wound of shoulder region |
| Open wound of testis with complication | Open wound of testis |
| Open wound of thigh with complication | Open wound of thigh |
| Open wound of throat without complication | Open wound of throat |
| Open wound of thumb with complication | Open wound of thumb |
| Open wound of toe with complication | Open wound of toe |
| Open wound of toe without complication | Open wound of toe |
| Open wound of toe(s) with complication | Open wound of toe |
| Open wound of tongue without complication | Open wound of tongue |
| Open wound of trachea with complication | Open wound of trachea |
| Open wound of trachea without complication | Open wound of trachea |
| Open wound of trunk with complication | Open wound of trunk |
| Open wound of trunk without complication | Open wound of trunk |
| Open wound of upper arm with complication | Open wound of upper arm |
| Open wound of upper limb with complication | Open wound of upper limb |
| Open wound of vagina with complication | Open wound of vagina |
| Open wound of vulva with complication | Open wound of vulva |
| Open wound of vulva without complication | Open wound of vulva |
| Open wound with complication | Open wound |
| Open wound without complication | Open wound |
| Operative cholangiography through cystic duct | Intraoperative fluoroscopic cholangiography with contrast through cystic duct |
| Oral contrast cholangiography | None |
| Oral contrast cholecystography | None |
| Oral contrast duodenography | None |
| Oral ulceration due to radiation burn | None |
| Organic solvent product | None |
| Osmotic diuretic agent | Osmotic diuretic |
| Osteoarthritis deformans | None |
| Osteoarthritis of hip co-occurrent and due to dysplasia | None |
| Outlet pelvic contraction with antenatal problem | Outlet contraction of pelvis |
| Oxazolidinone antibacterial agent | None |
| Oxygen saturation above reference range | Oxygen saturation above reference range |
| Oxytocic agent | Oxytocic agent |
| Packing sinus | None |
| Pain and tenderness | None |
| Pancreatic operative cystography | None |
| Pancreatic operative loopography | None |
| Pantothenic acid supplement agent | Pantothenic acid supplement |
| Parallel beam scanography | None |
| Parasitophobia | None |
| Parotid sialogram | None |
| Partial epilepsy with autonomic symptoms | Focal epilepsy |
| Partial epilepsy with impairment of consciousness | Focal epilepsy |
| Partial frontal lobe epilepsy | Frontal lobe epilepsy |
| Partial occipital lobe epilepsy | Occipital lobe epilepsy |
| Partial parietal lobe epilepsy | Parietal lobe epilepsy |
| Passive immunity stimulant agent | None |
| Patching – action | Closure – action |
| Patient advised to inform DVLA | None |
| Patient lifting system lift pants | Patient lifting system walking sling |
| Patient reassurance | Reassuring |
| Paw-paw | None |
| Pediculicide agent | Insecticide |
| Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with antenatal problem | Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium |
| Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with postnatal complication | Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium |
| Penicillin antibacterial agent | None |
| Penicillinase-resistant penicillin antibacterial agent | None |
| Penicillinase-sensitive penicillin antibacterial agent | None |
| Percutaneous angioplasty of popliteal artery | None |
| Percutaneous angioplasty of pulmonary artery | None |
| Percutaneous cholangiography | Percutaneous fluoroscopic cholangiography |
| Percutaneous cholecystogram | None |
| Percutaneous hepatography | Fluoroscopic percutaneous transhepatic cholangiography with contrast |
| Percutaneous hysterogram | Fluoroscopic hysterography with contrast |
| Percutaneous pancreatogram | None |
| Percutaneous subintimal angioplasty | None |
| Percutaneous thrombolysis of coronary artery | None |
| Percutaneous transhepatic cholangiography | Fluoroscopic percutaneous transhepatic cholangiography with contrast |
| Percutaneous transhepatic cholangiography guided laparoscopic biopsy of bile duct with contrast | Percutaneous transhepatic fluoroscopic cholangiography guided laparoscopic biopsy of bile duct with contrast |
| Percutaneous transjejunal cholangiogram | Percutaneous transjejunal fluoroscopic cholangiography with contrast |
| Percutaneous transluminal angioplasty of artery of upper limb | None |
| Percutaneous transluminal angioplasty of axillary artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of brachial artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of celiac artery | None |
| Percutaneous transluminal angioplasty of common femoral artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of common iliac artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of inferior mesenteric artery | None |
| Percutaneous transluminal angioplasty of internal iliac artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of popliteal artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of profunda femoris artery using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of pulmonary vein using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal angioplasty of superior mesenteric artery | None |
| Percutaneous transluminal angioplasty of superior vena cava | None |
| Percutaneous transluminal angioplasty using fluoroscopic guidance with contrast | None |
| Percutaneous transluminal balloon angioplasty of artery | None |
| Percutaneous transluminal balloon angioplasty of pulmonary artery | None |
| Percutaneous transluminal coronary angioplasty | None |
| Percutaneous transluminal insertion of stent into aorta | None |
| Percutaneous transluminal insertion of stent into pulmonary artery | None |
| Perforating ulcer of the foot | Neuropathic ulcer of foot |
| Pericardial contrast radiography | None |
| Pericondylar part of femur | None |
| Perineogram | None |
| Peripheral neuritis in pregnancy with postnatal complication | Peripheral neuritis in pregnancy |
| Pernasal tube cholangiogram | None |
| Peroral cholangiography | None |
| Peroral cholecystography abnormal | None |
| Peroral cholecystography normal | None |
| Persistent hymen affecting obstetric care | None |
| Persistent hymen affecting pregnancy | None |
| Persistent hymen in pregnancy, childbirth and the puerperium | None |
| Personal care needs met | None |
| Pesticide product | Pesticide |
| Phalloplasty | Construction of penis |
| Pharmaceutical fluid or solution | Pharmaceutical fluid or solution agent |
| Phlebitis of superior longitudinal sinus | None |
| Phosphorus supplement agent | Phosphorus supplement |
| Pigmenting agent | Pigment |
| Placental polyp with postnatal complication | Placental polyp |
| Placental vasography | None |
| Placentography | None |
| Placentography abnormal | Ultrasonography of placenta abnormal |
| Placentography normal | Ultrasonography of placenta normal |
| Placentography requested | Ultrasonography of placenta requested |
| Placentography-contrast | None |
| Plasma expander | Plasma expander |
| Pleura transplantation | None |
| Pleural empyema with no fistula | Empyema of pleura |
| Pleuromutilin antibacterial agent | None |
| Pneumography of peritoneal cavity | None |
| Pneumography of retroperitoneum | None |
| Pneumogynecography | Fluoroscopic hysterosalpingography with contrast |
| Pneumohysterosalpingography | Fluoroscopic hysterosalpingography with contrast |
| Podophyllotoxin and/or podophyllotoxin derivative antineoplastic agent | None |
| Polyhydramnios with antenatal problem | Polyhydramnios |
| Polymyxin antibacterial agent | None |
| Polystomatic sublingual gland | Sublingual gland structure |
| Positive contrast meatogram | None |
| Post-delivery acute renal failure with postnatal problem | Postpartum acute renal failure |
| Post-dysenteric arthropathy | None |
| Post-dysenteric reactive arthropathy of the pelvic region and thigh | None |
| Posterior fossa brain malformation, haemaniogma, arterial anomaly, cardiac defect and aortic coarctation, eye abnormality synodrome and sternal anomaly syndrome | PHACES syndrome |
| Postoperative cholangiography | Postoperative fluoroscopic cholangiography with contrast |
| Postoperative pancreatography | None |
| Postpartum coagulation defects with postnatal problem | Postpartum coagulation defects |
| Potassium supplement agent | Potassium supplement |
| Potassium-sparing diuretic agent | Potassium-sparing diuretic |
| Pouchogram | Fluoroscopy of ileal pouch with contrast |
| Precipitate labor with antenatal problem | Precipitate labor |
| Pre-eclampsia or eclampsia with pre-existing hypertension with postnatal complication | Pre-eclampsia or eclampsia with pre-existing hypertension |
| Prefabricated stainless steel crown, permanent tooth | Restoration of permanent tooth with preformed stainless steel crown |
| Prefabricated stainless steel crown, primary tooth | Restoration of deciduous tooth with preformed stainless steel crown |
| Pregnancy with mental disorders | None |
| Pregnant abdomen finding | None |
| Pregnant woman | Pregnancy |
| Premature rupture of membranes with antenatal problem | Premature rupture of membranes |
| Prenatal vitamin | Vitamin |
| Prepectinate part of anal canal | None |
| Primary carcinoma ventral surface of tongue | None |
| Primary insertion of spacer into lumbar interspinous process | Insertion of spacer into lumbar interspinous process |
| Primary Klatskin tumor | Primary perihilar cholangiocarcinoma |
| Primary microsurgical graft to peripheral nerve | Microsurgical graft to peripheral nerve |
| Primary pigmented nodular adrenocortical disease | None |
| Primary uterine inertia with antenatal problem | Primary uterine inertia |
| Procedure on coronary artery using imaging guidance | None |
| Prograde operative pancreatography | None |
| Prolapsed arm with antenatal problem | Presentation of prolapsed arm of fetus |
| Prolonged artificial rupture of membranes with antenatal problem | Prolonged artificial rupture of membranes |
| Prolonged first stage with antenatal problem | Prolonged first stage of labor |
| Prolonged second stage with antenatal problem | Prolonged second stage of labor |
| Prone body position for tube feeding of patient | Prone body position for tube feeding |
| Prostatitis category III | None |
| Prosthetic graft patch angioplasty | None |
| Proton therapy | None |
| Provision of services and equipment | Equipment-related management procedure |
| Pseudallescheria boydii and/or Scedosporium boydii complex | Scedosporium apiospermum complex |
| Psychodynamic attachment finding | Interpersonal attachment finding |
| Psychomotor epilepsy | Temporal lobe epilepsy |
| Psychosensory epilepsy | Epilepsy |
| Psychostimulant | Psychostimulant |
| Puerperal cerebrovascular disorder with antenatal complication | Cerebrovascular disorder in the puerperium |
| Puerperal cerebrovascular disorder with postnatal complication | None |
| Puerperal endometritis with postnatal complication | Puerperal endometritis |
| Puerperal peritonitis with postnatal complication | Puerperal peritonitis |
| Puerperal salpingitis with postnatal complication | Puerperal salpingitis |
| Puerperal sepsis with postnatal complication | Puerperal sepsis |
| Purine analog antineoplastic agent | None |
| Purine and/or purine derivative diuretic agent | None |
| Pyridoxine supplement agent | Vitamin B6 supplement |
| Pyrimidine analog antineoplastic agent | None |
| Quinolone antibacterial agent | None |
| Radiation damage to brachial plexus | None |
| Radiation-induced mucositis of oral mucous membranes | None |
| Radiculography | None |
| Radioactive drug therapy | None |
| Radiochemotherapy: to stop spread | Combined chemotherapy and radiation therapy |
| Radiographic contrast media | Contrast media |
| Radiographic measurement of lung volume | None |
| Radiographic procedure on genitourinary system | None |
| Radiography of gastrointestinal tract | None |
| Radiography of kidney-ureter-bladder | None |
| Radiography of left bronchus with contrast | None |
| Radiography of nasolacrimal duct | None |
| Radiography of right bronchus with contrast | None |
| Radiography of urinary system | None |
| Radiolabeled antibody therapy | None |
| Radiologic examination of colon by air contrast | None |
| Radiologic examination of pharynx and cervical esophagus | None |
| Radiologic examination of renal cyst, translumbar approach | None |
| Radiologic examination of upper gastrointestinal tract and small bowel with serial films | None |
| Radiologic examination of upper gastrointestinal tract with KUB | None |
| Radiologic guidance for dilation of urethra | None |
| Radiologic guidance for ileal conduitogram | Fluoroscopic ileal conduitography |
| Radiologic guidance for percutaneous placement of enteroclysis tube | None |
| Radionecrosis of skin due to and following diagnostic procedure | Radionecrosis of skin due to and following radiotherapy |
| Radionuclide generators | None |
| Radionuclide therapy for glandular suppression | None |
| Radiopharmaceuticals | Radioactive isotope |
| Radiosensitizing measure | None |
| Radiotherapy: infuse skull/brain | None |
| rcT2mi | None |
| Reactive arthritis co-occurrent and due to nonspecific urethritis | None |
| Reactive arthritis due to and following dysentery | None |
| Recent weight gain | None |
| Recent weight loss | None |
| Reconstruction of breast with expander or prosthesis | None |
| Reconstruction of tendon pulley with graft or local tissue | None |
| Rectocele affecting obstetric care | Rectocele in pregnancy, childbirth and puerperium |
| Recurrent benign focal seizures of childhood | Self-limited focal epilepsy |
| Recurrent complex partial epilepsy | None |
| Region of proximal femur | None |
| Region of proximal left femur | None |
| Region of proximal right femur | None |
| Region of thorax | Thoracic structure |
| Removal of impacted tooth, completely bony, with unusual surgical complications | Removal of impacted tooth, completely bony |
| Renal function study with serial imaging | None |
| Repair by nailing | None |
| Repair of artery with patch graft | None |
| Repair of artery with synthetic, Dacron or Teflon patch graft | None |
| Repair of bilateral direct and indirect inguinal hernias with prosthesis or graft | None |
| Repair of bilateral direct inguinal hernias with prosthesis or graft | None |
| Repair of bilateral femoral hernias with prosthesis or graft | None |
| Repair of bilateral indirect inguinal hernias with prosthesis or graft | None |
| Repair of bilateral inguinal hernias with prosthesis or graft | None |
| Repair of blood vessel with patch graft | None |
| Repair of blood vessel with synthetic, Dacron or Teflon patch graft | None |
| Repair of inguinal hernia with prosthesis or graft, direct | None |
| Repair of inguinal hernia with prosthesis or graft, indirect | None |
| Repair of recurrence | Repair – action |
| Repair of vaginal wall prolapse | None |
| Replacement of percutaneous drainage catheter with contrast monitoring | Fluoroscopy guided percutaneous replacement of catheter with contrast |
| Replacement preparation | Replacement agent |
| Requires assistance with all activities of daily living | None |
| Respiratory rate AND/OR rhythm finding | None |
| Restoration, crown, resin with predominantly base metal | Restoration of tooth with resin and base metal crown |
| Restoration, resin | None |
| Retained placenta with no hemorrhage with postnatal problem | Retained placenta, without hemorrhage |
| Retained products of conception with no hemorrhage with postnatal problem | Retained products of conception with no hemorrhage |
| Retracted nipple in pregnancy, the puerperium or lactation with antenatal complication | Retracted nipple in pregnancy, the puerperium or lactation |
| Retracted nipple in pregnancy, the puerperium or lactation with postnatal complication | Retracted nipple in pregnancy, the puerperium or lactation |
| Retrograde bulb ureteropyelography | Fluoroscopic retrograde ureteropyelography |
| Retrograde cystourethrogram | Fluoroscopic retrograde cystourethrography |
| Retrograde operative pancreatography | None |
| Retrograde urethrogram | Fluoroscopic retrograde urethrography |
| Retrograde urography with KUB | Fluoroscopic retrograde pyelography |
| Retroperitoneal fistulography with contrast | None |
| Reversal rotation-plasty of ankle | None |
| Rhesus isoimmunization with antenatal problem | Rhesus isoimmunization affecting pregnancy |
| Rhinencephalic epilepsy | Temporal lobe epilepsy |
| Riboflavin supplement agent | Riboflavin supplement |
| Rifamycin antibacterial agent | None |
| Right intrahepatic bile duct branches | None |
| Rigid perineum affecting obstetric care | None |
| Rokitansky sequence | Mayer Rokitansky Küster Hauser syndrome |
| Rubella with neurological complication | Rubella |
| Rupture of uterus before labor with antenatal problem | Rupture of uterus before onset of labor |
| Salpingography | None |
| Sample broken | Device containing specimen broken |
| Scabicide agent | Scabicide |
| SCID (severe combined immunodeficiency) due to absent class II HLA (human leukocyte antigens) | None |
| Sclerosant agent | None |
| Scoliosis myelogram | None |
| Scratch of head and neck | None |
| Screening for drug abuse | None |
| Second degree perineal tear during delivery with postnatal problem | Second degree perineal laceration |
| Second generation cephalosporin antibacterial agent | None |
| Secondary microsurgical graft to peripheral nerve | None |
| Secondary uterine inertia with antenatal problem | Secondary uterine inertia |
| Sedative agent | Sedative |
| Selective angiocardiography | Fluoroscopic selective angiocardiography with contrast |
| Selective bronchography | Fluoroscopic selective bronchography with contrast |
| Selenium supplement agent | Selenium supplement |
| Septate vagina affecting obstetric care | Septate vagina in pregnancy, childbirth and the puerperium |
| Severe combined immunodeficiency due to CARD11 deficiency | Combined immunodeficiency due to CARD11 deficiency |
| Severe pre-eclampsia with postnatal complication | Severe pre-eclampsia |
| Sex of baby | None |
| Sex of baby at delivery | None |
| Shoulder dystocia with antenatal problem | Shoulder girdle dystocia |
| Signs/symptoms-mental/emotional case management | None |
| Signs/symptoms-mental/emotional education, guidance, and counseling | None |
| Signs/symptoms-mental/emotional surveillance | None |
| Silver polishers’ lung disease | None |
| Single energy X-ray photon absorptiometry | Dual energy X-ray absorptiometry |
| Sinogram of abdominal wall with contrast | None |
| Sinogram with contrast | None |
| Skeletal muscle relaxant | Skeletal muscle relaxant |
| Skin graft disorder | Disorder following skin grafting procedure |
| Skin of extremity transplantation | None |
| Skin of head transplantation | None |
| Skin of neck transplantation | None |
| Skin of trunk transplantation | None |
| Smooth muscle relaxant | Smooth muscle relaxant |
| Sneezing symptom | Sneezing |
| Social needs met | None |
| Sodium supplement agent | Sodium supplement |
| Somatosensory epilepsy | Parietal lobe epilepsy |
| Specialization of anal canal | None |
| Specific blood vessel imaging | Angiography |
| Specific imaging methods | Imaging |
| Specific skeletal imaging | Imaging of skeletal system |
| Specific soft tissue imaging | Imaging of soft tissue |
| Spinal cord transplantation | None |
| Splenoportography, positive contrast | None |
| Stenosis of vagina affecting obstetric care | Stenosis of vagina in pregnancy, childbirth and the puerperium |
| Stereographic radiography | Stereographic technique |
| Stereotactic/stereoscopic investigation | None |
| Stereotactic/stereoscopic test – abdomen | None |
| Stereotactic/stereoscopic test – brain | None |
| Stereotactic/stereoscopic test – face | None |
| Stereotactic/stereoscopic test – heart | None |
| Stereotactic/stereoscopic test – lungs | None |
| Stereotactic/stereoscopic test – mediastinum | None |
| Stereotactic/stereoscopic test – skeleton | None |
| Stereotactic/stereoscopic test – skull | None |
| Steroid dependence | None |
| Steroid withdrawal syndrome | None |
| Stimulant | Stimulant |
| Streptogramin antibacterial agent | None |
| Struck by missile | None |
| Structure of anal sinus | None |
| Structure of bone marrow of pelvis and/or femur | None |
| Structure of femur | None |
| Structure of internal glandular zone of prostate | None |
| Structure of lateral part of body of tongue | None |
| Structure of left femur | None |
| Structure of nasopharyngeal gland | None |
| Structure of palatine portion of dorsum of tongue | None |
| Structure of right femur | None |
| Structure of undescended left testis | Undescended left testicle |
| Structure of undescended right testis | Undescended right testicle |
| Subintimal angioplasty | None |
| Submandibular sialogram | None |
| Submissive attachment | None |
| Substance abuse | None |
| Sulfonamide antibacterial agent | None |
| Sulfonamide diuretic agent | None |
| Sulfur supplement agent | Sulfur supplement |
| Summitt syndrome | Acrocephalopolysyndactyly type II |
| Sunitinib 12.5 mg oral capsule | None |
| Sunitinib 25 mg oral capsule | None |
| Sunitinib 50 mg oral capsule | None |
| Supervision – normal delivery | None |
| Supine body position for tube feeding of patient | Supine body position for tube feeding |
| Suppressed lactation with antenatal complication | Suppressed lactation |
| Suppressed lactation with postnatal complication | Suppressed lactation |
| Supracervical hysterectomy | None |
| Surgical drainage – action | None |
| Surgical tissue adhesive | Surgical adhesive |
| Suspected abuse hard drugs | Suspected substance use disorder |
| Suspected abuse soft drugs | Suspected substance use disorder |
| Suspected alcohol abuse | Suspected alcohol use disorder |
| Suspected drug abuse | Suspected substance use disorder |
| Sympathoparetic pupil caused by drug | None |
| Symptomatic chloasma | Chloasma |
| Symptomatic diabetic peripheral neuropathy absent | Diabetic peripheral neuropathy absent |
| Symptomatic disorders in pregnancy | Disorder of pregnancy |
| Symptomatic disorders of the gastrointestinal tract | Disorder of gastrointestinal tract |
| Symptomatic disorders of the urinary tract | Disorder of urinary system |
| Symptomatic exhibitionism | Exhibitionism |
| Symptomatic fetishism | Fetishism |
| Symptomatic inflammatory myopathy | Myositis |
| Symptomatic inflammatory myopathy associated with another disorder | Myositis |
| Symptomatic late congenital syphilis | Late congenital syphilis (2 years or more) |
| Symptomatic myoclonus | Myoclonic disorder |
| Symptomatic nystagmus | Nystagmus |
| Symptomatic pedophilia | Pedophilia |
| Symptomatic postprocedural ovarian failure | Postprocedural ovarian failure |
| Symptomatic sexual masochism | Sexual masochism |
| Symptomatic sexual sadism | Sexual sadism |
| Symptomatic torsion dystonia | Torsion dystonia |
| T tube cholangiogram | Fluoroscopic T tube cholangiography with contrast |
| Tendon graft | None |
| Tendon grafted | None |
| Tendon transplantation | None |
| Terminal insomnia | None |
| Termination of pregnancy without complication | Termination of pregnancy |
| Tetracyclic antidepressant agent | None |
| Tetracycline antibacterial agent | None |
| Therapeutic drug dependence | None |
| Therapeutic radioisotope | Radioactive isotope |
| Thiamine supplement agent | Thiamine supplement |
| Thiazide diuretic agent | None |
| Third degree perineal tear during delivery with postnatal problem | Third degree perineal laceration |
| Third generation cephalosporin antibacterial agent | None |
| Thoracic aortography, positive contrast | None |
| Thoracic myelography | None |
| Thorax transplantation | None |
| Three female babies | Number of female fetuses |
| Three male babies | Number of male fetuses |
| Thrombolytic agent | Thrombolytic agent |
| Thrombophlebitis of superior longitudinal venous sinus | None |
| Thrombosis of superior longitudinal sinus | None |
| Thyroid tumor/metastasis irradiation | None |
| Tocolytic agent | None |
| Tongue graft | None |
| Tophus of right foot co-occurrent and due to gout | None |
| Total care needs met | None |
| Tracheo-esophageal fistula X-ray study | None |
| Tracheography | None |
| Transcricoid bronchography | None |
| Transcricoid radiography of bilateral bronchi with contrast | None |
| Transglottic radiography of bilateral bronchi with contrast | None |
| Transient hypertension of pregnancy with postnatal complication | Transient hypertension of pregnancy |
| Transmission bone density study | None |
| Transplant of hair follicles to scalp | None |
| Transplant of salivary duct opening | None |
| Transplant of tissue of anus | None |
| Transplantation between systems | Transplantation to recipient |
| Transplantation of abdominal tissue | None |
| Transplantation of aberrant renal vein | None |
| Transplantation of accessory sinus mucosa | None |
| Transplantation of brain tissue | None |
| Transplantation of cranial nerve | None |
| Transplantation of dura | None |
| Transplantation of fascia of hand | None |
| Transplantation of gracilis muscle | None |
| Transplantation of hair follicles of eyebrow | None |
| Transplantation of hair follicles of eyelid | None |
| Transplantation of hand muscle | None |
| Transplantation of heart valve | None |
| Transplantation of mesenteric tissue | None |
| Transplantation of nerve | None |
| Transplantation of peripheral nerve | None |
| Transplantation of peritoneal tissue | None |
| Transplantation of pharyngeal tissue | None |
| Transplantation of prostatic tissue | None |
| Transplantation of retroperitoneal tissue | None |
| Transplantation of salivary gland duct | None |
| Transplantation of scrotal tissue | None |
| Transplantation of seminal vesicle | None |
| Transplantation of temporalis muscle | None |
| Transplantation of thyroid tissue | None |
| Transplantation of tissue into brain | None |
| Transplantation of tissue into nervous system | None |
| Transplantation of tissue into spinal cord | None |
| Transplantation of tissue of accessory sinus | None |
| Transplantation of tissue of ankle | None |
| Transplantation of tissue of chest wall | None |
| Transplantation of tissue of diaphragm | None |
| Transplantation of tissue of esophagus | None |
| Transplantation of tissue of foot | None |
| Transplantation of tissue of forearm | None |
| Transplantation of tissue of hand | None |
| Transplantation of tissue of inguinal region | None |
| Transplantation of tissue of lower leg | None |
| Transplantation of tissue of lower limb | None |
| Transplantation of tissue of mediastinum | None |
| Transplantation of tissue of nasopharynx | None |
| Transplantation of tissue of nose | None |
| Transplantation of tissue of pelvic region | None |
| Transplantation of tissue of perineum | None |
| Transplantation of tissue of rectum | None |
| Transplantation of tissue of shoulder | None |
| Transplantation of tissue of stomach | None |
| Transplantation of tissue of thigh | None |
| Transplantation of tissue of upper arm | None |
| Transplantation of tissue of upper limb | None |
| Transplantation of tissue of urinary bladder | None |
| Transplantation of tissue of wrist | None |
| Transplantation of tonsil and adenoid | None |
| Transplantation of urethral tissue | None |
| Transplantation of uterine tissue | None |
| Transplantation of vaginal tissue | None |
| Transplantation of vas deferens | None |
| Transplantation of vulvar tissue | None |
| Transurethral removal of internal dwelling ureteral stent using radiologic guidance | Fluoroscopy guided transurethral removal of ureteral stent |
| Transverse lie with antenatal problem | Transverse lie |
| Traumatic amputation of finger with complication | Traumatic amputation of finger |
| Traumatic amputation of finger without complication | Traumatic amputation of finger |
| Traumatic amputation of thumb AND/OR fingers of one hand with complication | Traumatic amputation of digit of hand |
| Traumatic amputation of thumb AND/OR fingers of one hand without complication | Traumatic amputation of digit of hand |
| Traumatic bilateral amputation of leg with complication | Bilateral traumatic amputation of lower limbs |
| Triazene antineoplastic agent | None |
| Triazole antifungal agent | None |
| Tricyclic antidepressant agent | None |
| Trochanteric transplant | Osteotomy and transfer of greater trochanter |
| Trunk transplantation | None |
| Tube feeding by Barron pump | Enteral feeding |
| Tube feeding of patient | None |
| Tumor imaging agent | None |
| Tumor of anterior two-thirds of tongue – lateral margin | None |
| Tumor of anterior two-thirds of tongue – ventral surface | None |
| Tumor of uterine body affecting obstetric care | Tumor of uterine body in pregnancy, childbirth and the puerperium |
| Twin pregnancy with antenatal problem | Twin pregnancy |
| Two female babies | Number of female fetuses |
| Two male and one female babies | None |
| Two male babies | Number of male fetuses |
| Type 2 diabetes mellitus without complication | Type 2 diabetes mellitus |
| U tube cholangiography | None |
| Ultrasound contrast media | Ultrasound contrast media |
| Umbilical cord tight around neck with antenatal problem | Umbilical cord around neck |
| Undescended testis | Undescended testicle |
| Unstable lie with antenatal problem | Unstable lie |
| Upper gastrointestinal tract examination with air contrast with KUB | None |
| Urethra injury – obstetric | None |
| Urethrogram | Fluoroscopic urethrography |
| Uricosuric agent | Uricosuric agent |
| US scan of soft tissues of leg | None |
| Uterine cervix transplantation | None |
| Uterine fibroid affecting obstetric care | Uterine fibroids in pregnancy, childbirth and the puerperium |
| Vaginal abnormality affecting obstetric care | Vaginal abnormality in pregnancy, childbirth and the puerperium |
| Vaginal enterocelectomy | None |
| Van Hoorn maneuver | Obstetrics manipulation |
| Vasa previa with antenatal problem | Vasa previa |
| Vascular fistulogram with contrast | None |
| Vasodilator agent | Vasodilator |
| Vasopressor agent | Vasopressor |
| Venogram – pertrochanteric | None |
| Vertebral column transplantation | None |
| Villonodular synovitis of multiple sites | Diffuse tenosynovial giant cell tumor |
| Vinca alkaloid antineoplastic agent | None |
| Visceral epilepsy | Focal epilepsy |
| Viscosity modifier | Viscosity modifier |
| Vitamin A supplement agent | Vitamin A supplement |
| Vitamin supplement agent | Vitamin supplement |
| Vitellointestinal structure | None |
| Voiding urethrocystography | Fluoroscopic micturating cystourethrography |
| Water soluble contrast myelogram | None |
| Weight decreasing | Weight decreased |
| Weight increasing | Weight increased |
| Weight loss | None |
| WHODAS (World Health Organization Disability Assessment Schedule) 2.0 | None |
| WHODAS (World Health Organization Disability Assessment Schedule) 2.0 score | None |
| Wiring of teeth | None |
| X-ray contrast media | Contrast media |
| X-ray of gastrointestinal tract abnormal | None |
| X-ray of genitourinary system abnormal | None |
| X-ray photon absorptiometry | Dual energy X-ray absorptiometry |